Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.
Inflammation of the retinal vasculature with various causes including infectious disease; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; BEHCET SYNDROME; and CHORIORETINITIS.
Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.
Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61)
A form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized ARTERIES, often with microaneurysms. It is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. Polyarteritis nodosa with lung involvement is called CHURG-STRAUSS SYNDROME.
Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.
Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.
Necrotizing VASCULITIS of small and medium size vessels, developing as a complication in RHEUMATOID ARTHRITIS patients. It is characterized by peripheral vascular lesions, cutaneous ULCERS, peripheral GANGRENE, and MONONEURITIS MULTIPLEX.
A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.
A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.
INFLAMMATION of any ARTERIES.
An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY.
Abnormal immunoglobulins, especially IGG or IGM, that precipitate spontaneously when SERUM is cooled below 37 degrees Celsius. It is characteristic of CRYOGLOBULINEMIA.
A systemic autoimmune disorder that typically affects medium and large ARTERIES, usually leading to occlusive granulomatous vasculitis with transmural infiltrate containing multinucleated GIANT CELLS. The TEMPORAL ARTERY is commonly involved. This disorder appears primarily in people over the age of 50. Symptoms include FEVER; FATIGUE; HEADACHE; visual impairment; pain in the jaw and tongue; and aggravation of pain by cold temperatures. (From Adams et al., Principles of Neurology, 6th ed)
Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).
A chronic inflammatory process that affects the AORTA and its primary branches, such as the brachiocephalic artery (BRACHIOCEPHALIC TRUNK) and CAROTID ARTERIES. It results in progressive arterial stenosis, occlusion, and aneurysm formation. The pulse in the arm is hard to detect. Patients with aortitis syndrome often exhibit retinopathy.
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
Mercury chloride (HgCl2). A highly toxic compound that volatizes slightly at ordinary temperature and appreciably at 100 degrees C. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant.
A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES.
Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region.
Antibodies obtained from a single clone of cells grown in mice or rats.
A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.
A PREDNISOLONE derivative with similar anti-inflammatory action.
Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions.
A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis.
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Pathological developments in the CECUM.
Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis.
'Skin diseases' is a broad term for various conditions affecting the skin, including inflammatory disorders, infections, benign and malignant tumors, congenital abnormalities, and degenerative diseases, which can cause symptoms such as rashes, discoloration, eruptions, lesions, itching, or pain.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA.
Antibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS.
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
Fever in which the etiology cannot be ascertained.
Adrenal cortex hormones are steroid hormones produced by the outer portion of the adrenal gland, consisting of glucocorticoids, mineralocorticoids, and androgens, which play crucial roles in various physiological processes such as metabolism regulation, stress response, electrolyte balance, and sexual development and function.
Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Administration of high doses of pharmaceuticals over short periods of time.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.
Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.
The pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. It is distinct it from APOPTOSIS, which is a normal, regulated cellular process.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.

T lymphocyte adhesion mechanisms within inflamed human kidney: studies with a Stamper-Woodruff assay. (1/1603)

Renal inflammatory conditions are characterized by mononuclear cell recruitment to sites of inflammation. We have developed a modified Stamper-Woodruff assay system to analyze mechanisms of functional T cell adhesion to cryostat sections of renal biopsy material from patients with vasculitic glomerulonephritis (GN) and acute allograft rejection. Peripheral blood T cells adhered to intraglomerular, periglomerular, and tubulointerstitial regions of the cortex. Blocking monoclonal antibodies against tissue expressed ICAM-1, VCAM-1, and the CS-1 domain of fibronectin (CS-1Fn) differentially attenuated T cell adhesion. Glomerular adhesion in vasculitic GN and tubulointerstitial adhesion in acute rejection were particularly sensitive to both anti-ICAM-1 and anti-VCAM-1 antibodies, indicating a prominent role for ICAM-1 and VCAM-1 at glomerular sites in vasculitis and at tubulointerstitial sites in rejection. Furthermore, using KL/4 cells (LFA-1 expressing) and Jurkat cells (VLA-4 expressing), we demonstrated specific LFA-1/ICAM-1- and VLA-4/VCAM-1-mediated interactions within glomerular and tubulointerstitial compartments. Jurkat cells also adhered to VCAM-1-free sites, and binding was inhibitable by anti-CS-1Fn antibody, thereby demonstrating a role for VLA-4/fibronectin interactions especially at intraglomerular sites in acute rejection where VCAM-1 is notably absent. We therefore propose a prominent functional role for ICAM-1, VCAM-1, and CS-1 domain fibronectin in T cell recruitment to the inflamed kidney.  (+info)

The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. (2/1603)

BACKGROUND: The purpose of this study was to characterize the recently reported inhibition of myeloperoxidase (MPO) by ceruloplasmin and to determine whether this may be disturbed in the presence of anti-MPO antibodies. METHODS: Specificity of the binding between ceruloplasmin and MPO was confirmed by Western blotting and enzyme-linked immunosorbent assay (ELISA), and the enzymatic activity of MPO was measured in the presence of ceruloplasmin, affinity-purified anti-MPO antibodies, or both. The affinity of the binding between MPO and ceruloplasmin and MPO and the anti-MPO antibodies was measured using a biosensor, with the results confirmed by chaotrope ELISA. RESULTS: Affinity-purified anti-MPO antibodies from patients with microscopic polyangiitis and florid renal vasculitis inhibited the binding between ceruloplasmin and MPO to a maximum of 72.9 +/- 12.8%, whereas those from patients with Wegener's granulomatosis and only minimal renal involvement inhibited the binding to a maximum of only 36.8 +/- 10.9% (P < 0. 001), with comparable reversal of the ceruloplasmin-mediated inhibition of MPO activity. Measurement of the affinity of the interactions demonstrated that binding between MPO and the anti-MPO antibodies is stronger than that between MPO and ceruloplasmin (1.61 x 107 to 1.33 x 108 vs. 7.46 x 106 m-1), indicating that binding to the autoantibody would be favored in vivo. CONCLUSIONS: This study confirms a role for ceruloplasmin as a physiological inhibitor of MPO, and demonstrates how the inhibition may be disrupted in the presence of anti-MPO antibodies. Because a majority (16 of 21) of the antibodies did not themselves inhibit MPO activity, their interference with the inhibition mediated by ceruloplasmin may be brought about by steric hindrance consequent upon the binding of the antibody to a dominant epitope at or near the active site.  (+info)

Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia. (3/1603)

Candida kruzei-related systemic infections are increasing in frequency, particularly in patients receiving prophylaxis with antifungal triazoles. A Caucasian male with newly diagnosed acute myeloid leukaemia (AML M1) developed severe and persistent fever associated with a micropustular eruption scattered over the trunk and limbs during induction chemotherapy. Blood cultures grew Candida kruzei, and biopsies of the skin lesions revealed a candida vasculitis. He responded to high doses of liposomal amphotericin B and was discharged well from hospital.  (+info)

Kawasaki syndrome. (4/1603)

KS is a fascinating illness of childhood that has emerged over the last 30 years and is now recognized as the most common cause of acquired heart disease in children in the United States. It has a dramatic clinical presentation in most cases, but for a small number of cases that present with a more subtle disease there appears to be a greater risk of coronary artery complications. Progress has been made in the management of KS, but although the disease appears to be related to an infectious etiology, no infectious agent has been proven to be the cause. Finally, issues in long-term management and prognosis are yet to be clarified.  (+info)

Vasculitis in the Palmerston North mouse model of lupus: phenotype and cytokine production profile of infiltrating cells. (5/1603)

OBJECTIVE: To define the phenotype of cells in the perivascular and vascular infiltrates of Palmerston North (PN) mice and the cytokines that those cells produce. METHODS: Immunohistologic analysis, flow cytometric analysis, and reverse transcriptase-polymerase chain reaction (RT-PCR) studies were performed on tissues and cells from female PN mice and age-matched and sex-matched DBA/2 mice. RESULTS: With aging, PN mice developed a female-predominant, lupus-like disease, with a severe systemic mononuclear cell perivasculitis and vasculitis. The perivasculitis involved arteries and veins in kidney, liver, brain, and lung; the vasculitis predominantly involved veins and venules. The perivascular and vascular infiltrates in female PN mice were composed mainly of an unusual cell type that expressed phenotypic markers characteristic of both T cells (Thy1+, CD3+, CD4+, T cell receptor + [TCR+]) and B cells (B220+). In addition, the infiltrates contained a smaller number of conventional CD4+,B220- T cells and macrophages. Very few CD8+ T cells or surface Ig+ B cells were seen. Unlike the Thy1+,B220+ T cells present in MRL/lpr mice, most of which were CD4-,CD8- and TCRalpha/beta+, the majority of the Thy1+,B220+ T cells in the perivascular/vascular infiltrates of PN mice were CD4+ and expressed either TCRalpha/beta or TCRgamma/delta. By immunohistologic staining, the cells in the perivascular and vascular infiltrates in the kidneys of older PN mice were shown to produce interleukin-4 (IL-4), IL-6, and IL-10, but not IL-2, interferon-gamma, transforming growth factor beta, tumor necrosis factor alpha, or IL-1beta. By RT-PCR, the kidneys of older PN mice were found to express high levels of IL-4, IL-6, and IL-10 messenger RNA. CONCLUSION: The vascular and perivascular infiltrates in PN mice are composed predominantly of an unusual subpopulation of T cells that are Thy1+,B220+,CD4+,CD8-, express either TCRalpha/beta or TCRgamma/delta, and produce mainly type 2 cytokines. The exact role of these cells in the immunopathogenesis of lupus-like disease in PN mice remains to be elucidated.  (+info)

Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity. (6/1603)

Heating sera is used to inactivate complement but may affect the binding characteristics of autoantibodies. We studied the effect of heating sera from patients with systemic vasculitides and SLE on antibody binding to cultured human umbilical vein endothelial cells. Sera from 32 patients with systemic vasculitides, eight with SLE and 10 healthy controls were studied for anti-endothelial cell antibodies (AECA) using an ELISA before and after heating sera to 56 degrees C for 30 min. The median (range) AECA binding index in the patient group increased from 20% (0-153%) to 71.5% (10-259%) (P < 0.0001). The AECA binding index in the control group also increased from 14% (0-52%) to 90% (42-154%) (P < 0.0001). The increased binding was unaffected by the addition of fresh complement or removal of immune complexes and the increased binding after heating persisted even after cooling to 4 degrees C. Specificity experiments showed that after heating, the binding specificity of sera was lost. Removal of immunoglobulin with Protein A abolished the increased binding seen after heating. Heating sera increases AECA binding in both patient and control sera. The mechanism is probably non-specific damage to the immunoglobulin molecule, and heating sera should thus be avoided.  (+info)

Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. (7/1603)

Giant cell arteritis (GCA) is a systemic vasculitis preferentially affecting large and medium-sized arteries. Inflammatory infiltrates in the arterial wall induce luminal occlusion with subsequent ischemia and degradation of the elastic membranes, allowing aneurysm formation. To identify pathways relevant to the disease process, differential display-PCR was used. The enzyme aldose reductase (AR), which is implicated in the regulation of tissue osmolarity, was found to be upregulated in the arteritic lesions. Upregulated AR expression was limited to areas of tissue destruction in inflamed arteries, where it was detected in T cells, macrophages, and smooth muscle cells. The production of AR was highly correlated with the presence of 4-hydroxynonenal (HNE), a toxic aldehyde and downstream product of lipid peroxidation. In vitro exposure of mononuclear cells to HNE was sufficient to induce AR production. The in vivo relationship of AR and HNE was explored by treating human GCA temporal artery-severe combined immunodeficiency (SCID) mouse chimeras with the AR inhibitors Sorbinil and Zopolrestat. Inhibition of AR increased HNE adducts twofold and the number of apoptotic cells in the arterial wall threefold. These data demonstrate that AR has a tissue-protective function by preventing damage from lipid peroxidation. We propose that AR is an oxidative defense mechanism able to neutralize the toxic effects of lipid peroxidation and has a role in limiting the arterial wall injury mediated by reactive oxygen species.  (+info)

Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals. (8/1603)

BACKGROUND: Adenoviral constructs have been used for studies of injury-induced vascular hyperplasia in immunologically naive laboratory animals, but their usefulness for intra-arterial gene therapy may be limited by the prevalence of preexisting immunity to adenovirus in the patient population. Here, we explored the efficacy of adenovirus-mediated transfer of Fas ligand, a cytotoxic gene with immunomodulatory properties, in inhibiting injury-induced vascular lesion formation in both naive and immunologically primed animals. METHODS AND RESULTS: Lesion formation was evaluated in balloon-injured carotid arteries of naive and adenovirus-immunized rats that were infected with adenoviral constructs expressing Fas ligand (Ad-FasL), the cyclin-dependent kinase inhibitor p21 (Ad-p21), or beta-galactosidase (Ad-betagal). In naive rats, Ad-FasL induced apoptosis in medial vascular smooth muscle cells and inhibited intimal hyperplasia by 60% relative to Ad-betagal-treated vessels (P<0.05), whereas the cytostatic agent Ad-p21 decreased lesion size by 58% (P<0.05). In animals preimmunized with an adenoviral vector containing no transgene, Ad-FasL significantly inhibited neointima formation (73% reduction, P<0.05), but Ad-p21 failed to inhibit neointima formation relative to controls. Immunologically primed rats displayed robust T-cell infiltration in Ad-p21- and Ad-betagal-treated vessels, but T-cell infiltration was markedly attenuated in Ad-FasL-treated vessels. CONCLUSIONS: Our data demonstrate that adenovirus-mediated Fas ligand delivery can inhibit intimal hyperplasia in both immunologically primed and naive animals, whereas the efficacy of an adenovirus-mediated p21 delivery is limited to immunologically naive animals. This study documents, for the first time, the therapeutic efficacy of intravascular adenoviral gene transfer in animals with preexisting immunity to adenovirus.  (+info)

Vasculitis is a group of disorders characterized by inflammation of the blood vessels, which can cause changes in the vessel walls including thickening, narrowing, or weakening. These changes can restrict blood flow, leading to organ and tissue damage. The specific symptoms and severity of vasculitis depend on the size and location of the affected blood vessels and the extent of inflammation. Vasculitis can affect any organ system in the body, and its causes can vary, including infections, autoimmune disorders, or exposure to certain medications or chemicals.

Systemic vasculitis is a group of disorders characterized by inflammation of the blood vessels (vasculitis) that can affect various organs and systems throughout the body. This condition can cause damage to the walls of the blood vessels, leading to narrowing, blockage, or weakening of the vessel walls, which can further result in reduced blood flow, tissue damage, and organ dysfunction.

The symptoms of systemic vasculitis depend on the severity and location of the affected blood vessels. They may include fever, fatigue, weight loss, joint pain, skin rashes or lesions, muscle weakness, nerve damage, and organ dysfunction such as kidney failure, lung disease, or gastrointestinal bleeding.

Systemic vasculitis can be caused by various factors, including infections, autoimmune diseases, medications, and underlying medical conditions. The diagnosis of systemic vasculitis typically involves a combination of physical examination, laboratory tests, imaging studies, and sometimes biopsy of the affected tissue. Treatment may include corticosteroids, immunosuppressive drugs, and other medications to control inflammation and prevent organ damage.

Retinal vasculitis is a medical condition characterized by inflammation of the blood vessels in the retina, which is the light-sensitive tissue located at the back of the eye. This condition can cause damage to the retina and may lead to vision loss if not treated promptly. The inflammation can affect both the small and large blood vessels in the retina and can occur as a result of various systemic diseases or infections, including autoimmune disorders, tuberculosis, syphilis, and toxoplasmosis. In some cases, retinal vasculitis may also be associated with uveitis, which is inflammation of the middle layer of the eye. Treatment typically involves addressing the underlying cause of the inflammation and may include corticosteroids or other immunosuppressive therapies to reduce inflammation and prevent further damage to the retina.

Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) is a group of autoimmune diseases characterized by inflammation and damage to small blood vessels, particularly capillaries, venules, and arterioles. The condition is named after the presence of ANCAs in the patient's serum, which are autoantibodies that target specific proteins in the neutrophil cytoplasm.

AAV includes several subtypes, including:

1. Granulomatosis with Polyangiitis (GPA, formerly known as Wegener's granulomatosis) - a form of AAV that typically affects the respiratory tract and kidneys, characterized by the presence of granulomas (clusters of inflammatory cells).
2. Microscopic Polyangiitis (MPA) - a form of AAV that primarily affects small vessels in various organs, such as the kidneys, lungs, and skin.
3. Eosinophilic Granulomatosis with Polyangiitis (EGPA, formerly known as Churg-Strauss syndrome) - a form of AAV that involves asthma, allergies, and eosinophilia (an increased number of eosinophils in the blood), along with vasculitis affecting various organs.

The exact cause of ANCA-Associated Vasculitis is not fully understood, but it is believed to involve an interplay between genetic factors, environmental triggers, and dysregulation of the immune system. The condition can lead to a wide range of symptoms depending on which organs are affected, including fever, fatigue, weight loss, joint pain, skin rashes, cough, shortness of breath, nosebleeds, and kidney problems. Treatment typically involves immunosuppressive medications to control inflammation and prevent further damage to the affected organs.

Vasculitis, Central Nervous System (CNS), refers to a group of disorders characterized by inflammation of blood vessels within the brain and/or spinal cord. This inflammation can cause damage to the blood vessel walls, leading to narrowing, blocking or weakening of the vessels, and in some cases, formation of aneurysms or rupture of the vessels.

The causes of CNS vasculitis are varied and can include infections, autoimmune diseases, medications, and unknown factors. The symptoms of CNS vasculitis depend on the severity and location of the inflammation, and may include headache, seizures, stroke-like symptoms (such as weakness or numbness in the face, arms, or legs), cognitive changes, and in severe cases, coma.

Diagnosis of CNS vasculitis typically involves a combination of clinical evaluation, imaging studies (such as MRI or angiography), and laboratory tests (including blood tests and analysis of cerebrospinal fluid). Treatment may involve corticosteroids, immunosuppressive medications, and/or other therapies aimed at reducing inflammation and preventing further damage to the blood vessels.

Polyarteritis nodosa (PAN) is a rare, systemic necrotizing vasculitis that affects medium-sized and small muscular arteries. It is characterized by inflammation and damage to the walls of the arteries, leading to the formation of microaneurysms (small bulges in the artery wall) and subsequent narrowing or complete occlusion of the affected vessels. This can result in tissue ischemia (reduced blood flow) and infarction (tissue death), causing a wide range of clinical manifestations that vary depending on the organs involved.

The exact cause of PAN remains unclear, but it is believed to involve an autoimmune response triggered by various factors such as infections or exposure to certain drugs. The diagnosis of PAN typically requires a combination of clinical findings, laboratory tests, and imaging studies, often supported by histopathological examination of affected tissues. Treatment usually involves the use of immunosuppressive medications to control inflammation and prevent further damage to the arteries and organs.

Churg-Strauss syndrome (CSS), also known as eosinophilic granulomatosis with polyangiitis (EGPA), is a rare autoimmune disorder characterized by inflammation of small- to medium-sized blood vessels (vasculitis) and the presence of eosinophils, a type of white blood cell. The syndrome typically affects multiple organ systems, including the respiratory tract, peripheral nerves, skin, heart, and kidneys.

The classic triad of symptoms includes asthma, allergies, and peripheral blood eosinophilia (high levels of eosinophils in the blood). Other common features include sinusitis, rhinitis, cough, shortness of breath, skin rashes, neuropathy (nerve damage), and cardiac involvement.

The exact cause of Churg-Strauss syndrome is not well understood, but it is believed to involve an abnormal immune response in genetically susceptible individuals. Treatment typically involves the use of immunosuppressive medications to control inflammation and prevent organ damage. Corticosteroids are often used as a first-line therapy, while other agents such as cyclophosphamide or rituximab may be added for more severe cases.

Vascular skin diseases are a group of medical conditions that affect the blood vessels in the skin. These disorders can be caused by problems with the structure or function of the blood vessels, which can lead to various symptoms such as redness, discoloration, pain, itching, and ulcerations. Some examples of vascular skin diseases include:

1. Rosacea: a chronic skin condition that causes redness, flushing, and visible blood vessels in the face.
2. Eczema: a group of inflammatory skin conditions that can cause redness, itching, and dryness. Some types of eczema, such as varicose eczema, are associated with problems with the veins.
3. Psoriasis: an autoimmune condition that causes red, scaly patches on the skin. Some people with psoriasis may also develop psoriatic arthritis, which can affect the blood vessels in the skin and joints.
4. Vasculitis: a group of conditions that cause inflammation of the blood vessels. This can lead to symptoms such as redness, pain, and ulcerations.
5. Livedo reticularis: a condition that causes a net-like pattern of discoloration on the skin, usually on the legs. It is caused by abnormalities in the small blood vessels.
6. Henoch-Schönlein purpura: a rare condition that causes inflammation of the small blood vessels, leading to purple spots on the skin and joint pain.
7. Raynaud's phenomenon: a condition that affects the blood vessels in the fingers and toes, causing them to become narrow and restrict blood flow in response to cold temperatures or stress.

Treatment for vascular skin diseases depends on the specific condition and its severity. It may include medications, lifestyle changes, and in some cases, surgery.

Rheumatoid vasculitis is not a term that is typically used as a formal medical diagnosis. However, it refers to a condition where there is inflammation of the blood vessels (vasculitis) in individuals with rheumatoid arthritis (RA).

Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints, causing inflammation and pain. In some people with severe RA, the immune system can also attack the blood vessels, leading to rheumatoid vasculitis. This condition is relatively rare, affecting less than 1% of people with rheumatoid arthritis.

Rheumatoid vasculitis can affect small and medium-sized blood vessels throughout the body, but it most commonly affects the skin, nerves, and organs such as the heart and lungs. Symptoms may include skin ulcers, nodules, or discoloration; nerve damage causing numbness, tingling, or weakness; and organ damage leading to symptoms related to the affected organ.

The diagnosis of rheumatoid vasculitis is typically made based on a combination of clinical examination, laboratory tests, and imaging studies. Treatment usually involves immunosuppressive medications to control the overactive immune system and reduce inflammation.

Microscopic Polyangiitis (MPA) is a rare type of vasculitis, which is a group of disorders that cause inflammation in the blood vessels. In MPA, the small blood vessels in various organs become inflamed and damaged, leading to symptoms that can affect multiple organ systems.

The term "microscopic" refers to the fact that the diagnosis of this condition typically requires examination of tissue samples under a microscope to see the characteristic patterns of inflammation and damage in the small blood vessels.

MPA is an autoimmune disorder, which means that the body's immune system mistakenly attacks its own tissues and organs. In MPA, the immune system produces abnormal antibodies called ANCA (antineutrophil cytoplasmic antibodies) that target certain proteins in the white blood cells, leading to their activation and subsequent damage to the blood vessels.

The symptoms of MPA can vary widely depending on which organs are affected, but they may include fever, fatigue, weight loss, joint pain, skin rashes, cough, shortness of breath, and kidney problems such as proteinuria and hematuria. Treatment typically involves the use of immunosuppressive medications to suppress the overactive immune system and reduce inflammation in the blood vessels.

Henoch-Schönlein purpura (HSP) is a type of small vessel vasculitis, which is a condition characterized by inflammation of the blood vessels. HSP primarily affects children, but it can occur in adults as well. It is named after two German physicians, Eduard Heinrich Henoch and Johann Schönlein, who first described the condition in the mid-19th century.

The main feature of HSP is a purpuric rash, which is a type of rash that appears as small, red or purple spots on the skin. The rash is caused by leakage of blood from the small blood vessels (capillaries) beneath the skin. In HSP, this rash typically occurs on the legs and buttocks, but it can also affect other parts of the body, such as the arms, face, and trunk.

In addition to the purpuric rash, HSP is often accompanied by other symptoms, such as joint pain and swelling, abdominal pain, nausea, vomiting, and diarrhea. In severe cases, it can also affect the kidneys, leading to hematuria (blood in the urine) and proteinuria (protein in the urine).

The exact cause of HSP is not known, but it is thought to be related to an abnormal immune response to certain triggers, such as infections or medications. Treatment typically involves supportive care, such as pain relief and fluid replacement, as well as medications to reduce inflammation and suppress the immune system. In most cases, HSP resolves on its own within a few weeks or months, but it can lead to serious complications in some individuals.

Cryoglobulinemia is a medical condition characterized by the presence of abnormal proteins called cryoglobulins in the blood. These proteins become insoluble at lower temperatures and can form immune complexes that can cause inflammation and damage to small blood vessels when they precipitate in cooler parts of the body.

Cryoglobulinemia is often associated with underlying conditions such as autoimmune diseases (such as rheumatoid arthritis or lupus), chronic infections (such as hepatitis C), and certain types of cancer (such as lymphoma). Symptoms can vary widely, but may include purpura (purple spots on the skin), joint pain, peripheral neuropathy (nerve damage causing numbness or weakness), fatigue, and kidney problems.

The diagnosis of cryoglobulinemia is typically made by detecting cryoglobulins in the blood through a special test that requires the blood sample to be kept at cold temperatures. Treatment for cryoglobulinemia depends on the underlying cause, but may include medications such as corticosteroids, immunosuppressants, or chemotherapy drugs.

Arteritis is a medical condition characterized by inflammation of the arteries. It is also known as vasculitis of the arteries. The inflammation can cause the walls of the arteries to thicken and narrow, reducing blood flow to affected organs or tissues. There are several types of arteritis, including:

1. Giant cell arteritis (GCA): Also known as temporal arteritis, it is a condition that mainly affects the large and medium-sized arteries in the head and neck. The inflammation can cause headaches, jaw pain, scalp tenderness, and vision problems.
2. Takayasu's arteritis: This type of arteritis affects the aorta and its major branches, mainly affecting young women. Symptoms include fever, weight loss, fatigue, and decreased pulse in the arms or legs.
3. Polyarteritis nodosa (PAN): PAN is a rare systemic vasculitis that can affect medium-sized arteries throughout the body. It can cause a wide range of symptoms, including fever, rash, abdominal pain, and muscle weakness.
4. Kawasaki disease: This is a type of arteritis that mainly affects children under the age of 5. It causes inflammation in the blood vessels throughout the body, leading to fever, rash, swollen lymph nodes, and red eyes.

The exact cause of arteritis is not fully understood, but it is believed to be an autoimmune disorder, where the body's immune system mistakenly attacks its own tissues. Treatment for arteritis typically involves medications to reduce inflammation and suppress the immune system.

Mucocutaneous Lymph Node Syndrome is also known as Kawasaki Disease. It is a type of vasculitis that primarily affects young children, usually those under the age of 5. The disease is named after Dr. Tomisaku Kawasaki, who first described it in Japan in 1967.

The condition is characterized by inflammation of the mucous membranes (mucosa), skin (cutaneous), and lymph nodes. The symptoms typically include fever, rash, red eyes, swollen lips and tongue, strawberry tongue, and swollen lymph nodes in the neck. In addition, children with Kawasaki disease may also experience joint pain, diarrhea, vomiting, and abdominal pain.

In severe cases, Kawasaki disease can lead to complications such as coronary artery aneurysms, which can increase the risk of heart attacks and other cardiovascular problems. The exact cause of Kawasaki disease is unknown, but it is thought to be triggered by an infection or other environmental factor in genetically susceptible children. Treatment typically involves administering high doses of intravenous immunoglobulin (IVIG) and aspirin to reduce inflammation and prevent complications.

Behçet syndrome is a rare inflammatory disease that can cause symptoms in various parts of the body. It's characterized by recurrent mouth sores (aphthous ulcers), genital sores, and inflammation of the eyes (uveitis). The condition may also cause skin lesions, joint pain and swelling, and inflammation of the digestive tract, brain, or spinal cord.

The exact cause of Behçet syndrome is not known, but it's thought to be an autoimmune disorder, in which the body's immune system mistakenly attacks its own healthy cells and tissues. The condition tends to affect men more often than women and typically develops during a person's 20s or 30s.

There is no cure for Behçet syndrome, but treatments can help manage symptoms and prevent complications. Treatment options may include medications such as corticosteroids, immunosuppressants, and biologics to reduce inflammation, as well as pain relievers and other supportive therapies.

Glomerulonephritis is a medical condition that involves inflammation of the glomeruli, which are the tiny blood vessel clusters in the kidneys that filter waste and excess fluids from the blood. This inflammation can impair the kidney's ability to filter blood properly, leading to symptoms such as proteinuria (protein in the urine), hematuria (blood in the urine), edema (swelling), hypertension (high blood pressure), and eventually kidney failure.

Glomerulonephritis can be acute or chronic, and it may occur as a primary kidney disease or secondary to other medical conditions such as infections, autoimmune disorders, or vasculitis. The diagnosis of glomerulonephritis typically involves a combination of medical history, physical examination, urinalysis, blood tests, and imaging studies, with confirmation often requiring a kidney biopsy. Treatment depends on the underlying cause and severity of the disease but may include medications to suppress inflammation, control blood pressure, and manage symptoms.

Cryoglobulins are immunoglobulins (a type of antibody) that precipitate or become insoluble at reduced temperatures, typically below 37°C (98.6°F), and re-dissolve when rewarmed. They can be found in various clinical conditions such as infections, inflammatory diseases, and lymphoproliferative disorders.

The presence of cryoglobulins in the blood can lead to a variety of symptoms, including purpura (a type of skin rash), arthralgias (joint pain), neuropathy (nerve damage), and glomerulonephritis (kidney inflammation). The diagnosis of cryoglobulinemia is made by detecting the presence of cryoglobulins in the serum, which requires special handling and processing of the blood sample. Treatment of cryoglobulinemia depends on the underlying cause and may include medications such as corticosteroids, immunosuppressive agents, or targeted therapies.

Giant Cell Arteritis (GCA), also known as Temporal Arteritis, is a chronic inflammatory disease affecting large and medium-sized arteries, most commonly the temporal artery. It primarily occurs in people over 50 years old. The condition is characterized by the infiltration of the artery walls with immune cells, leading to inflammation, swelling, and damage. This can restrict blood flow, causing various symptoms.

The key feature of GCA is the presence of multinucleated giant cells, which are large collections of fused immune cells, in the affected artery walls. These cells are a hallmark of this condition when viewed under a microscope.

Common symptoms include new onset of severe headaches, scalp tenderness, jaw pain while chewing (called jaw claudication), vision problems, and systemic symptoms such as fever, fatigue, and weight loss. If left untreated, GCA can lead to serious complications like blindness or stroke. Treatment typically involves high-dose corticosteroids to reduce inflammation and prevent further damage.

Purpura is a medical term that refers to the appearance of purple-colored spots on the skin or mucous membranes, caused by bleeding underneath the skin due to various factors such as blood clotting disorders, vasculitis (inflammation of the blood vessels), severe thrombocytopenia (low platelet count), or use of certain medications. These spots can vary in size and shape, ranging from small pinpoint hemorrhages (petechiae) to larger, irregularly shaped patches (ecchymoses). The bleeding is usually not caused by trauma or injury to the area. It's important to consult a healthcare professional if you notice any unexplained purpuric spots on your skin or mucous membranes, as they can indicate an underlying medical condition that requires further evaluation and treatment.

Takayasu arteritis is a rare inflammatory disease that affects the large blood vessels in the body, most commonly the aorta and its main branches. It's also known as pulseless disease or aortic arch syndrome. The condition primarily affects young to middle-aged women, although it can occur in anyone at any age.

The inflammation caused by Takayasu arteritis can lead to narrowing, thickening, and weakening of the affected blood vessels' walls, which can result in reduced blood flow to various organs and tissues. This can cause a variety of symptoms depending on the severity and location of the vessel involvement.

Common symptoms include:

* Weak or absent pulses in the arms and/or legs
* High blood pressure (hypertension)
* Dizziness, lightheadedness, or fainting spells due to reduced blood flow to the brain
* Headaches
* Visual disturbances
* Fatigue
* Weight loss
* Night sweats
* Fever

Diagnosis of Takayasu arteritis typically involves a combination of medical history, physical examination, laboratory tests, and imaging studies. Treatment usually includes corticosteroids or other immunosuppressive medications to control inflammation and maintain remission. Regular follow-up with a healthcare provider is essential to monitor disease activity and adjust treatment as necessary.

Autoimmune diseases are a group of disorders in which the immune system, which normally protects the body from foreign invaders like bacteria and viruses, mistakenly attacks the body's own cells and tissues. This results in inflammation and damage to various organs and tissues in the body.

In autoimmune diseases, the body produces autoantibodies that target its own proteins or cell receptors, leading to their destruction or malfunction. The exact cause of autoimmune diseases is not fully understood, but it is believed that a combination of genetic and environmental factors contribute to their development.

There are over 80 different types of autoimmune diseases, including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, Hashimoto's thyroiditis, Graves' disease, psoriasis, and inflammatory bowel disease. Symptoms can vary widely depending on the specific autoimmune disease and the organs or tissues affected. Treatment typically involves managing symptoms and suppressing the immune system to prevent further damage.

Immunosuppressive agents are medications that decrease the activity of the immune system. They are often used to prevent the rejection of transplanted organs and to treat autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. These drugs work by interfering with the immune system's normal responses, which helps to reduce inflammation and damage to tissues. However, because they suppress the immune system, people who take immunosuppressive agents are at increased risk for infections and other complications. Examples of immunosuppressive agents include corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, tacrolimus, and sirolimus.

Autoantibodies are defined as antibodies that are produced by the immune system and target the body's own cells, tissues, or organs. These antibodies mistakenly identify certain proteins or molecules in the body as foreign invaders and attack them, leading to an autoimmune response. Autoantibodies can be found in various autoimmune diseases such as rheumatoid arthritis, lupus, and thyroiditis. The presence of autoantibodies can also be used as a diagnostic marker for certain conditions.

Mercuric chloride, also known as corrosive sublimate, is defined medically as a white or colorless crystalline compound used historically as a topical antiseptic and caustic. It has been used in the treatment of various skin conditions such as warts, thrush, and some parasitic infestations. However, its use is limited nowadays due to its high toxicity and potential for serious side effects, including kidney damage, digestive problems, and nervous system disorders. It is classified as a hazardous substance and should be handled with care.

Leg dermatoses is a general term that refers to various skin conditions affecting the legs. This can include a wide range of inflammatory, infectious, or degenerative diseases that cause symptoms such as redness, itching, scaling, blistering, or pigmentation changes on the leg skin. Examples of specific leg dermatoses include stasis dermatitis, venous eczema, contact dermatitis, lichen planus, psoriasis, and cellulitis among others. Accurate diagnosis usually requires a thorough examination and sometimes a biopsy to determine the specific type of dermatosis and appropriate treatment.

Plasmapheresis is a medical procedure where the liquid portion of the blood (plasma) is separated from the blood cells. The plasma, which may contain harmful substances such as antibodies or toxins, is then removed and replaced with fresh plasma or a plasma substitute. The remaining blood cells are mixed with the new plasma and returned to the body. This process is also known as therapeutic plasma exchange (TPE). It's used to treat various medical conditions including certain autoimmune diseases, poisonings, and neurological disorders.

Urticaria, also known as hives, is an allergic reaction that appears on the skin. It is characterized by the rapid appearance of swollen, pale red bumps or plaques (wheals) on the skin, which are often accompanied by itching, stinging, or burning sensations. These wheals can vary in size and shape, and they may change location and appear in different places over a period of hours or days. Urticaria is usually caused by an allergic reaction to food, medication, or other substances, but it can also be triggered by physical factors such as heat, cold, pressure, or exercise. The condition is generally harmless, but severe cases of urticaria may indicate a more serious underlying medical issue and should be evaluated by a healthcare professional.

Prednisolone is a synthetic glucocorticoid drug, which is a class of steroid hormones. It is commonly used in the treatment of various inflammatory and autoimmune conditions due to its potent anti-inflammatory and immunosuppressive effects. Prednisolone works by binding to specific receptors in cells, leading to changes in gene expression that reduce the production of substances involved in inflammation, such as cytokines and prostaglandins.

Prednisolone is available in various forms, including tablets, syrups, and injectable solutions. It can be used to treat a wide range of medical conditions, including asthma, rheumatoid arthritis, inflammatory bowel disease, allergies, skin conditions, and certain types of cancer.

Like other steroid medications, prednisolone can have significant side effects if used in high doses or for long periods of time. These may include weight gain, mood changes, increased risk of infections, osteoporosis, diabetes, and adrenal suppression. As a result, the use of prednisolone should be closely monitored by a healthcare professional to ensure that its benefits outweigh its risks.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that can affect almost any organ or system in the body. In SLE, the immune system produces an exaggerated response, leading to the production of autoantibodies that attack the body's own cells and tissues, causing inflammation and damage. The symptoms and severity of SLE can vary widely from person to person, but common features include fatigue, joint pain, skin rashes (particularly a "butterfly" rash across the nose and cheeks), fever, hair loss, and sensitivity to sunlight.

Systemic lupus erythematosus can also affect the kidneys, heart, lungs, brain, blood vessels, and other organs, leading to a wide range of symptoms such as kidney dysfunction, chest pain, shortness of breath, seizures, and anemia. The exact cause of SLE is not fully understood, but it is believed to involve a combination of genetic, environmental, and hormonal factors. Treatment typically involves medications to suppress the immune system and manage symptoms, and may require long-term management by a team of healthcare professionals.

An antigen-antibody complex is a type of immune complex that forms when an antibody binds to a specific antigen. An antigen is any substance that triggers an immune response, while an antibody is a protein produced by the immune system to neutralize or destroy foreign substances like antigens.

When an antibody binds to an antigen, it forms a complex that can be either soluble or insoluble. Soluble complexes are formed when the antigen is small and can move freely through the bloodstream. Insoluble complexes, on the other hand, are formed when the antigen is too large to move freely, such as when it is part of a bacterium or virus.

The formation of antigen-antibody complexes plays an important role in the immune response. Once formed, these complexes can be recognized and cleared by other components of the immune system, such as phagocytes, which help to prevent further damage to the body. However, in some cases, the formation of large numbers of antigen-antibody complexes can lead to inflammation and tissue damage, contributing to the development of certain autoimmune diseases.

Temporal arteries are the paired set of arteries that run along the temples on either side of the head. They are branches of the external carotid artery and play a crucial role in supplying oxygenated blood to the scalp and surrounding muscles. One of the most common conditions associated with temporal arteries is Temporal Arteritis (also known as Giant Cell Arteritis), which is an inflammation of these arteries that can lead to serious complications like vision loss if not promptly diagnosed and treated.

Monoclonal murine-derived antibodies are a type of laboratory-produced antibody that is identical in structure, having been derived from a single clone of cells. These antibodies are created using mouse cells and are therefore composed entirely of mouse immune proteins. They are designed to bind specifically to a particular target protein or antigen, making them useful tools for research, diagnostic testing, and therapeutic applications.

Monoclonal antibodies offer several advantages over polyclonal antibodies (which are derived from multiple clones of cells and can recognize multiple epitopes on an antigen). Monoclonal antibodies have a consistent and uniform structure, making them more reliable for research and diagnostic purposes. They also have higher specificity and affinity for their target antigens, allowing for more sensitive detection and measurement.

However, there are some limitations to using monoclonal murine-derived antibodies in therapeutic applications. Because they are composed entirely of mouse proteins, they can elicit an immune response in humans, leading to the production of human anti-mouse antibodies (HAMA) that can neutralize their effectiveness. To overcome this limitation, researchers have developed chimeric and humanized monoclonal antibodies that incorporate human protein sequences, reducing the risk of an immune response.

Cogan syndrome is a rare inflammatory disorder that affects the eyes and inner ear. It is characterized by the combination of non-syphilitic interstitial keratitis (inflammation of the cornea) and vestibuloauditory dysfunction (damage to the inner ear causing balance problems and hearing loss).

The symptoms of Cogan syndrome can develop suddenly or gradually, and they may include:

* Redness, pain, and blurry vision in one or both eyes
* Sensitivity to light
* Hearing loss, often sudden and progressive, affecting one or both ears
* Vertigo (a spinning sensation) and balance problems
* Tinnitus (ringing or buzzing in the ears)
* Nausea and vomiting

The exact cause of Cogan syndrome is not known, but it is believed to be an autoimmune disorder, in which the body's immune system mistakenly attacks healthy tissues. Treatment typically involves the use of corticosteroids and other immunosuppressive drugs to reduce inflammation and prevent further damage. In severe cases, aggressive treatment with biologic agents may be necessary.

It is important to note that Cogan syndrome is a rare condition, affecting only about 1 in 500,000 people worldwide. If you are experiencing symptoms of this disorder, it is important to seek medical attention from a healthcare professional who has experience diagnosing and treating rare inflammatory disorders.

Methylprednisolone is a synthetic glucocorticoid drug, which is a class of hormones that naturally occur in the body and are produced by the adrenal gland. It is often used to treat various medical conditions such as inflammation, allergies, and autoimmune disorders. Methylprednisolone works by reducing the activity of the immune system, which helps to reduce symptoms such as swelling, pain, and redness.

Methylprednisolone is available in several forms, including tablets, oral suspension, and injectable solutions. It may be used for short-term or long-term treatment, depending on the condition being treated. Common side effects of methylprednisolone include increased appetite, weight gain, insomnia, mood changes, and increased susceptibility to infections. Long-term use of methylprednisolone can lead to more serious side effects such as osteoporosis, cataracts, and adrenal suppression.

It is important to note that methylprednisolone should be used under the close supervision of a healthcare provider, as it can cause serious side effects if not used properly. The dosage and duration of treatment will depend on various factors such as the patient's age, weight, medical history, and the condition being treated.

Plasma exchange, also known as plasmapheresis, is a medical procedure where the liquid portion of the blood (plasma) is separated from the blood cells. The plasma, which may contain harmful substances such as antibodies, clotting factors, or toxins, is then removed and replaced with fresh plasma or a plasma substitute. This process helps to remove the harmful substances from the blood and allows the body to replenish its own plasma with normal components. Plasma exchange is used in the treatment of various medical conditions including autoimmune diseases, poisonings, and certain types of kidney diseases.

The Arthus reaction is a type of localized immune complex-mediated hypersensitivity reaction (type III hypersensitivity). It is named after the French scientist Nicolas Maurice Arthus who first described it in 1903. The reaction occurs when an antigen is injected into the skin or tissues of a sensitized individual, leading to the formation of immune complexes composed of antigens and antibodies (usually IgG). These immune complexes deposit in the small blood vessels, causing complement activation, recruitment of inflammatory cells, and release of mediators that result in tissue damage.

Clinically, an Arthus reaction is characterized by localized signs of inflammation, such as redness, swelling, pain, and warmth at the site of antigen injection. In severe cases, it can lead to necrosis and sloughing of the skin. The Arthus reaction typically occurs within 2-8 hours after antigen exposure and is distinct from immediate hypersensitivity reactions (type I), which occur within minutes of antigen exposure.

The Arthus reaction is often seen in laboratory animals used for antibody production, where repeated injections of antigens can lead to sensitization and subsequent Arthus reactions. In humans, it can occur as a complication of immunizations or diagnostic tests that involve the injection of foreign proteins or drugs. To prevent Arthus reactions, healthcare providers may perform skin testing before administering certain medications or vaccines to assess for preexisting sensitization.

Cyclophosphamide is an alkylating agent, which is a type of chemotherapy medication. It works by interfering with the DNA of cancer cells, preventing them from dividing and growing. This helps to stop the spread of cancer in the body. Cyclophosphamide is used to treat various types of cancer, including lymphoma, leukemia, multiple myeloma, and breast cancer. It can be given orally as a tablet or intravenously as an injection.

Cyclophosphamide can also have immunosuppressive effects, which means it can suppress the activity of the immune system. This makes it useful in treating certain autoimmune diseases, such as rheumatoid arthritis and lupus. However, this immunosuppression can also increase the risk of infections and other side effects.

Like all chemotherapy medications, cyclophosphamide can cause a range of side effects, including nausea, vomiting, hair loss, fatigue, and increased susceptibility to infections. It is important for patients receiving cyclophosphamide to be closely monitored by their healthcare team to manage these side effects and ensure the medication is working effectively.

Cecal diseases refer to medical conditions that affect the cecum, which is a pouch-like structure located at the junction of the small and large intestines. The cecum plays an important role in digestion, particularly in the fermentation of certain types of food.

There are several different types of cecal diseases, including:

1. Cecal volvulus: This is a rare condition in which the cecum twists on itself, cutting off blood flow and causing severe pain and other symptoms.
2. Diverticulitis: This occurs when small pouches called diverticula form in the wall of the cecum and become inflamed or infected.
3. Appendicitis: Although not strictly a cecal disease, the appendix is a small tube-like structure that branches off from the cecum. Inflammation of the appendix (appendicitis) can cause severe pain in the lower right abdomen and may require surgical removal of the appendix.
4. Crohn's disease: This is a chronic inflammatory bowel disease that can affect any part of the digestive tract, including the cecum.
5. Tuberculosis: The cecum can also be affected by tuberculosis, which is a bacterial infection that primarily affects the lungs but can spread to other parts of the body.
6. Cancer: Although rare, cancer can also affect the cecum, leading to symptoms such as abdominal pain, bloating, and changes in bowel habits.

Treatment for cecal diseases depends on the specific condition and its severity. Treatment options may include antibiotics, surgery, or other medical interventions. If you are experiencing symptoms that may be related to a cecal disease, it is important to seek medical attention promptly.

Serine endopeptidases are a type of enzymes that cleave peptide bonds within proteins (endopeptidases) and utilize serine as the nucleophilic amino acid in their active site for catalysis. These enzymes play crucial roles in various biological processes, including digestion, blood coagulation, and programmed cell death (apoptosis). Examples of serine endopeptidases include trypsin, chymotrypsin, thrombin, and elastase.

Skin diseases, also known as dermatological conditions, refer to any medical condition that affects the skin, which is the largest organ of the human body. These diseases can affect the skin's function, appearance, or overall health. They can be caused by various factors, including genetics, infections, allergies, environmental factors, and aging.

Skin diseases can present in many different forms, such as rashes, blisters, sores, discolorations, growths, or changes in texture. Some common examples of skin diseases include acne, eczema, psoriasis, dermatitis, fungal infections, viral infections, bacterial infections, and skin cancer.

The symptoms and severity of skin diseases can vary widely depending on the specific condition and individual factors. Some skin diseases are mild and can be treated with over-the-counter medications or topical creams, while others may require more intensive treatments such as prescription medications, light therapy, or even surgery.

It is important to seek medical attention if you experience any unusual or persistent changes in your skin, as some skin diseases can be serious or indicative of other underlying health conditions. A dermatologist is a medical doctor who specializes in the diagnosis and treatment of skin diseases.

Rheumatoid arthritis (RA) is a systemic autoimmune disease that primarily affects the joints. It is characterized by persistent inflammation, synovial hyperplasia, and subsequent damage to the articular cartilage and bone. The immune system mistakenly attacks the body's own tissues, specifically targeting the synovial membrane lining the joint capsule. This results in swelling, pain, warmth, and stiffness in affected joints, often most severely in the hands and feet.

RA can also have extra-articular manifestations, affecting other organs such as the lungs, heart, skin, eyes, and blood vessels. The exact cause of RA remains unknown, but it is believed to involve a complex interplay between genetic susceptibility and environmental triggers. Early diagnosis and treatment are crucial in managing rheumatoid arthritis to prevent joint damage, disability, and systemic complications.

Immune complex diseases are medical conditions that occur when the immune system produces an abnormal response to certain antigens, leading to the formation and deposition of immune complexes in various tissues and organs. These immune complexes consist of antibodies bound to antigens, which can trigger an inflammatory reaction and damage the surrounding tissue.

Immune complex diseases can be classified into two categories: acute and chronic. Acute immune complex diseases include serum sickness and hypersensitivity vasculitis, while chronic immune complex diseases include systemic lupus erythematosus (SLE), rheumatoid arthritis, and membranoproliferative glomerulonephritis.

The symptoms of immune complex diseases depend on the location and extent of tissue damage. They can range from mild to severe and may include fever, joint pain, skin rashes, kidney dysfunction, and neurological problems. Treatment typically involves medications that suppress the immune system and reduce inflammation, such as corticosteroids, immunosuppressants, and anti-inflammatory drugs.

Rheumatoid factor (RF) is an autoantibody, specifically an immunoglobulin M (IgM) antibody, that can be detected in the blood serum of some people with rheumatoid arthritis (RA), other inflammatory conditions, and infectious diseases. RF targets the Fc portion of IgG, leading to immune complex formation and subsequent inflammation, which contributes to the pathogenesis of RA. However, not all patients with RA test positive for RF, and its presence does not necessarily confirm a diagnosis of RA. Other conditions can also lead to elevated RF levels, such as infections, liver diseases, and certain malignancies. Therefore, the interpretation of RF results should be considered alongside other clinical, laboratory, and imaging findings for an accurate diagnosis and appropriate management.

Azathioprine is an immunosuppressive medication that is used to prevent the rejection of transplanted organs and to treat autoimmune diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease. It works by suppressing the activity of the immune system, which helps to reduce inflammation and prevent the body from attacking its own tissues.

Azathioprine is a prodrug that is converted into its active form, 6-mercaptopurine, in the body. This medication can have significant side effects, including decreased white blood cell count, increased risk of infection, and liver damage. It may also increase the risk of certain types of cancer, particularly skin cancer and lymphoma.

Healthcare professionals must carefully monitor patients taking azathioprine for these potential side effects. They may need to adjust the dosage or stop the medication altogether if serious side effects occur. Patients should also take steps to reduce their risk of infection and skin cancer, such as practicing good hygiene, avoiding sun exposure, and using sunscreen.

Fever of Unknown Origin (FUO) is a medical condition defined as a fever that remains undiagnosed after one week of inpatient evaluation or three days of outpatient evaluation, with temperatures repeatedly measuring at or above 38.3°C (101°F). The fevers can be continuous or intermittent and are often associated with symptoms such as fatigue, weight loss, and general malaise.

The causes of FUO can be broadly categorized into four groups: infections, inflammatory diseases, neoplasms (cancers), and miscellaneous conditions. Infections account for a significant proportion of cases, particularly in immunocompromised individuals. Other possible causes include connective tissue disorders, vasculitides, drug reactions, and factitious fever.

The diagnostic approach to FUO involves a thorough history and physical examination, laboratory tests, and imaging studies. The goal is to identify the underlying cause of the fever and provide appropriate treatment. In some cases, despite extensive evaluation, the cause may remain undiagnosed, and management focuses on supportive care and monitoring for any new symptoms or complications.

The adrenal cortex hormones are a group of steroid hormones produced and released by the outer portion (cortex) of the adrenal glands, which are located on top of each kidney. These hormones play crucial roles in regulating various physiological processes, including:

1. Glucose metabolism: Cortisol helps control blood sugar levels by increasing glucose production in the liver and reducing its uptake in peripheral tissues.
2. Protein and fat metabolism: Cortisol promotes protein breakdown and fatty acid mobilization, providing essential building blocks for energy production during stressful situations.
3. Immune response regulation: Cortisol suppresses immune function to prevent overactivation and potential damage to the body during stress.
4. Cardiovascular function: Aldosterone regulates electrolyte balance and blood pressure by promoting sodium reabsorption and potassium excretion in the kidneys.
5. Sex hormone production: The adrenal cortex produces small amounts of sex hormones, such as androgens and estrogens, which contribute to sexual development and function.
6. Growth and development: Cortisol plays a role in normal growth and development by influencing the activity of growth-promoting hormones like insulin-like growth factor 1 (IGF-1).

The main adrenal cortex hormones include:

1. Glucocorticoids: Cortisol is the primary glucocorticoid, responsible for regulating metabolism and stress response.
2. Mineralocorticoids: Aldosterone is the primary mineralocorticoid, involved in electrolyte balance and blood pressure regulation.
3. Androgens: Dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEAS) are the most abundant adrenal androgens, contributing to sexual development and function.
4. Estrogens: Small amounts of estrogens are produced by the adrenal cortex, mainly in women.

Disorders related to impaired adrenal cortex hormone production or regulation can lead to various clinical manifestations, such as Addison's disease (adrenal insufficiency), Cushing's syndrome (hypercortisolism), and congenital adrenal hyperplasia (CAH).

Intravenous Immunoglobulins (IVIG) are a preparation of antibodies, specifically immunoglobulins, that are derived from the plasma of healthy donors. They are administered intravenously to provide passive immunity and help boost the immune system's response in individuals with weakened or compromised immune systems. IVIG can be used for various medical conditions such as primary immunodeficiency disorders, secondary immunodeficiencies, autoimmune diseases, and some infectious diseases. The administration of IVIG can help prevent infections, reduce the severity and frequency of infections, and manage the symptoms of certain autoimmune disorders. It is important to note that while IVIG provides temporary immunity, it does not replace a person's own immune system.

Neutrophils are a type of white blood cell that are part of the immune system's response to infection. They are produced in the bone marrow and released into the bloodstream where they circulate and are able to move quickly to sites of infection or inflammation in the body. Neutrophils are capable of engulfing and destroying bacteria, viruses, and other foreign substances through a process called phagocytosis. They are also involved in the release of inflammatory mediators, which can contribute to tissue damage in some cases. Neutrophils are characterized by the presence of granules in their cytoplasm, which contain enzymes and other proteins that help them carry out their immune functions.

Peripheral Nervous System (PNS) diseases, also known as Peripheral Neuropathies, refer to conditions that affect the functioning of the peripheral nervous system, which includes all the nerves outside the brain and spinal cord. These nerves transmit signals between the central nervous system (CNS) and the rest of the body, controlling sensations, movements, and automatic functions such as heart rate and digestion.

PNS diseases can be caused by various factors, including genetics, infections, toxins, metabolic disorders, trauma, or autoimmune conditions. The symptoms of PNS diseases depend on the type and extent of nerve damage but often include:

1. Numbness, tingling, or pain in the hands and feet
2. Muscle weakness or cramps
3. Loss of reflexes
4. Decreased sensation to touch, temperature, or vibration
5. Coordination problems and difficulty with balance
6. Sexual dysfunction
7. Digestive issues, such as constipation or diarrhea
8. Dizziness or fainting due to changes in blood pressure

Examples of PNS diseases include Guillain-Barre syndrome, Charcot-Marie-Tooth disease, diabetic neuropathy, and peripheral nerve injuries. Treatment for these conditions varies depending on the underlying cause but may involve medications, physical therapy, lifestyle changes, or surgery.

Immunoglobulin G (IgG) is a type of antibody, which is a protective protein produced by the immune system in response to foreign substances like bacteria or viruses. IgG is the most abundant type of antibody in human blood, making up about 75-80% of all antibodies. It is found in all body fluids and plays a crucial role in fighting infections caused by bacteria, viruses, and toxins.

IgG has several important functions:

1. Neutralization: IgG can bind to the surface of bacteria or viruses, preventing them from attaching to and infecting human cells.
2. Opsonization: IgG coats the surface of pathogens, making them more recognizable and easier for immune cells like neutrophils and macrophages to phagocytose (engulf and destroy) them.
3. Complement activation: IgG can activate the complement system, a group of proteins that work together to help eliminate pathogens from the body. Activation of the complement system leads to the formation of the membrane attack complex, which creates holes in the cell membranes of bacteria, leading to their lysis (destruction).
4. Antibody-dependent cellular cytotoxicity (ADCC): IgG can bind to immune cells like natural killer (NK) cells and trigger them to release substances that cause target cells (such as virus-infected or cancerous cells) to undergo apoptosis (programmed cell death).
5. Immune complex formation: IgG can form immune complexes with antigens, which can then be removed from the body through various mechanisms, such as phagocytosis by immune cells or excretion in urine.

IgG is a critical component of adaptive immunity and provides long-lasting protection against reinfection with many pathogens. It has four subclasses (IgG1, IgG2, IgG3, and IgG4) that differ in their structure, function, and distribution in the body.

Pulse therapy, in the context of drug treatment, refers to a therapeutic regimen where a medication is administered in large doses for a short period of time, followed by a break or "drug-free" interval before the next dose. This cycle is then repeated at regular intervals. The goal of pulse therapy is to achieve high concentrations of the drug in the body to maximize its therapeutic effect while minimizing overall exposure and potential side effects.

This approach is often used for drugs that have a long half-life or slow clearance, as it allows for periodic "washing out" of the drug from the body. Pulse therapy can also help reduce the risk of developing drug resistance in certain conditions like rheumatoid arthritis and tuberculosis. Common examples include pulse methotrexate for rheumatoid arthritis and intermittent preventive treatment with anti-malarial drugs.

It is important to note that the use of pulse therapy should be based on a thorough understanding of the drug's pharmacokinetics, therapeutic index, and potential adverse effects. Close monitoring of patients undergoing pulse therapy is essential to ensure safety and efficacy.

Immunologic factors refer to the elements of the immune system that contribute to the body's defense against foreign substances, infectious agents, and cancerous cells. These factors include various types of white blood cells (such as lymphocytes, neutrophils, monocytes, and eosinophils), antibodies, complement proteins, cytokines, and other molecules involved in the immune response.

Immunologic factors can be categorized into two main types: innate immunity and adaptive immunity. Innate immunity is the non-specific defense mechanism that provides immediate protection against pathogens through physical barriers (e.g., skin, mucous membranes), chemical barriers (e.g., stomach acid, enzymes), and inflammatory responses. Adaptive immunity, on the other hand, is a specific defense mechanism that develops over time as the immune system learns to recognize and respond to particular pathogens or antigens.

Abnormalities in immunologic factors can lead to various medical conditions, such as autoimmune disorders, immunodeficiency diseases, and allergies. Therefore, understanding immunologic factors is crucial for diagnosing and treating these conditions.

Scleritis is a serious, painful inflammatory condition that affects the sclera, which is the white, tough outer coating of the eye. It can lead to severe pain, light sensitivity, and potential loss of vision if not promptly treated. Scleritis may occur in isolation or be associated with various systemic diseases such as rheumatoid arthritis, lupus, or granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis). Immediate medical attention is necessary for proper diagnosis and management.

Necrosis is the premature death of cells or tissues due to damage or injury, such as from infection, trauma, infarction (lack of blood supply), or toxic substances. It's a pathological process that results in the uncontrolled and passive degradation of cellular components, ultimately leading to the release of intracellular contents into the extracellular space. This can cause local inflammation and may lead to further tissue damage if not treated promptly.

There are different types of necrosis, including coagulative, liquefactive, caseous, fat, fibrinoid, and gangrenous necrosis, each with distinct histological features depending on the underlying cause and the affected tissues or organs.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Glucocorticoids are a class of steroid hormones that are naturally produced in the adrenal gland, or can be synthetically manufactured. They play an essential role in the metabolism of carbohydrates, proteins, and fats, and have significant anti-inflammatory effects. Glucocorticoids suppress immune responses and inflammation by inhibiting the release of inflammatory mediators from various cells, such as mast cells, eosinophils, and lymphocytes. They are frequently used in medical treatment for a wide range of conditions, including allergies, asthma, rheumatoid arthritis, dermatological disorders, and certain cancers. Prolonged use or high doses of glucocorticoids can lead to several side effects, such as weight gain, mood changes, osteoporosis, and increased susceptibility to infections.

"Vasculitis" at Dorland's Medical Dictionary "The Johns Hopkins Vasculitis Center - Symptoms of Vasculitis". Archived from the ... Vasculitis is primarily caused by leukocyte migration and resultant damage. Although both occur in vasculitis, inflammation of ... Conditions with leucocytoclasis mainly include hypersensitivity vasculitis (also called leukocytoclastic vasculitis) and ... "Vasculitis therapy refines vasculitis mechanistic classification". Autoimmunity Reviews. 20 (6): 102829. doi:10.1016/j.autrev. ...
... , exercise-induced vasculitis, Disney rash, and hiker's rash are names proposed by different medical ... Kelly, R I (Apr 2010). "Golfer's vasculitis vs cutaneous vasculitis exacerbated by activity". Archives of Dermatology. 146 (4 ... Nixon, Rosemary L; Opie, Jacinta M; Kelly, Robert I (2005). "Golfer's vasculitis". Med J Aust. 183 (1): 32. doi:10.5694/j.1326- ... Kelly, RI; Opie, J; Nixon, R (Feb 2005). "Golfer's vasculitis". The Australasian Journal of Dermatology. 46 (1): 11-4. doi: ...
... is a cutaneous condition characterized by an inflammation of blood vessels and the presence of ...
Necrotizing vasculitis, also called systemic necrotizing vasculitus, is a category of vasculitis, comprising vasculitides that ... There are several vasculitides that affect small vessels. Granulomatosis with polyangiitis. Systemic vasculitis of medium and ... Hypersensitivity vasculitis (allergic vasculitis). Usually due to a hypersensitivity reaction to a known drug. Drugs most ... Arteriograms are helpful in vasculitis affecting the large and medium vessels but not helpful in small vessel vasculitis. ...
... is skin condition that is a typical feature of rheumatoid arthritis, presenting as peripheral vascular ...
... most commonly affect the skin, causing a raised, pinpoint rash on the lower extremities known as ... Relapse in vasculitis refers to the recurrence or reactivation of disease symptoms and inflammation after a period of ... Cryoglobulinemic vasculitis is a form of inflammation affecting the blood vessels caused by the deposition of abnormal proteins ... Therefore, vasculitis generally occurs only in patients affected by mixed (type 2 and 3) cryoglobulinemia, as simple (type 1) ...
Drug-induced vasculitis may involve retina as well, as seen in methamphetamine induced vasculitis. Retinal vasculitis presents ... Retinal vasculitis is inflammation of the vascular branches of the retinal artery, caused either by primary ocular disease ... J. C. van Meurs, S. Lightman, P. W. T. De Waard et al., "Retinal vasculitis occurring with common variable immunodeficiency ... For those patients who present with only vasculitis of the retinal vessels, great investigative effort (Chest X-ray, blood test ...
... is featured prominently in the 2010 documentary film Fat, Sick and Nearly Dead. The main character and ... Cutaneous small-vessel vasculitis List of cutaneous conditions Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007 ... Urticarial vasculitis (also known as "chronic urticaria as a manifestation of venulitis", "hypocomplementemic urticarial ... The anti-C1q antibodies found in patients with hypocomplementemic urticarial vasculitis activate C1q, which instigates ...
... is a skin condition characterized by crops of small, tender, erythematous nodules on the legs, mostly on the ... Miroscopically there are epithelioid granulomas and vasculitis in the subcutaneous tissue, making it a form of panicullitis. ...
... is a complication of systemic lupus erythematosus in which the autoimmune response causes the deposition of ... Vasculitis more often affects younger men. Pyrpasopoulou, Athina; Chatzimichailidou, Sofia; Aslanidis, Spyros (2012). "Vascular ...
... (sometimes the word angiitis is used instead of "vasculitis") is vasculitis (inflammation of the blood ... "Central Nervous System Vasculitis (CNS Vasculitis)". Cleveland Clinic. Retrieved 1 May 2015. Scolding NJ, Wilson H, Hohlfeld R ... "Primary" angiitis/vasculitis of the central nervous system (PACNS) is said to be present if there is no underlying cause. The ... Cerebral vasculitis is a very rare condition that is difficult to diagnose, and as a result there are significant variations in ...
DermNet vascular/livedoid-vasculitis (Articles with short description, Short description is different from Wikidata, Vascular- ...
Subtypes of small-vessel vasculitis include:: 833-6 IgA vasculitis (Henoch-Schönlein purpura) Acute hemorrhagic edema of ... Urticarial vasculitis Cryoglobulinemic vasculitis Erythema elevatum diutinum Granuloma faciale ANCA-associated vasculitis ... cutaneous necrotizing vasculitis and cutaneous necrotizing venulitis, It is the most common form of vasculitis seen in clinical ... It is important to distinguish between IgA and non-IgA vasculitis. IgA vasculitis is more likely to present with abdominal pain ...
... (also known as Bullous variant of small vessel vasculitis) is a cutaneous condition in which ... patients with small vessel vasculitis will develop superimposed vesicles and bullae, especially on the distal extremities. ...
"Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register". Arthritis & ... Systemic vasculitides are a group of heterogeneous diseases that share the etiology in terms of inflammation of the blood ... Watts, Richard A.; Carruthers, David M.; Scott, David G.I. (August 1995). "Epidemiology of systemic vasculitis: Changing ... Gonzalez-Gay, Miguel A.; García-Porrúa, Carlos (September 1999). "Systemic Vasculitis in Adults in Northwestern Spain, 1988- ...
It causes vasculitis of the lower and upper respiratory tracts, and it also affects multiple organs, including eyes. Without ... Vasculitis. BMJ Publishing Group Ltd and European League Against Rheumatism: 1482.3-1483. doi:10.1136/annrheumdis-2018-eular. ...
... is also considered to be a primary childhood vasculitis, a disorder associated with vasculitis that mainly ... "necrotizing vasculitis - definition of necrotizing vasculitis". Free Online Medical Dictionary, Thesaurus and Encyclopedia. ... Under this classification scheme for systemic vasculitis, Kawasaki disease is considered to be a necrotizing vasculitis (also ... a predominantly medium-sized vessel vasculitis. It can also be classed as an autoimmune form of vasculitis. It is not ...
vasculitis. infectious mononucleosis peritonsillar abscess Laryngeal edema is a common cause of stridor post extubation ( ...
Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D (September 2015). "Cryoglobulinemia Vasculitis". The American Journal of ... vasculitis, sarcoidosis. Multiple sclerosis may also be causal. Vitamin deficiency states: Vitamin B12 (Methylcobalamin), ... Diabetes mellitus Vasculitides: polyarteritis nodosa, granulomatosis with polyangiitis and eosinophilic granulomatosis with ...
... as systemic disorder characterized by aseptic vasculitis granulomatous inflammation and vasculitis which affects the upper and ... "Videos: Granulomatosis with Polyangiitis". Vasculitis Foundation. Woywodt A, Haubitz M, Haller H, Matteson EL (2006). " ... the ACCP rescinded the prize and campaigned to rename Wegener's granulomatosis to ANCA-associated granulomatous vasculitis. ...
ISBN 978-0-12-385157-4. Khan, Haroon; Scott, David G. I.; Watts, Richard A. (2015). "5. Vasculitis". In Watts, Richard A.; ...
... vasculitis). It is an autoimmune disease and a form of vasculitis that affects small- and medium-size vessels in many organs ... Although GPA affects small- and medium-size vessels, it is formally classified as one of the small vessel vasculitides in the ... If the person has signs of kidney involvement or cutaneous vasculitis, a biopsy is obtained from the kidneys. On rare occasions ... Bruce IN, Bell AL (April 1997). "A comparison of two nomenclature systems for primary systemic vasculitis". British Journal of ...
"Systemic Vasculitis." Pg. 65-67. 2009, ACP. "American College of Physicians , Internal Medicine , ACP". Archived from the ... There is irregular fibrosis of the blood vessels due to chronic vasculitis, leading to sometimes massive intimal fibrosis ( ... The age at onset helps to differentiate Takayasu's arteritis from other types of large vessel vasculitis. For example, ... RA Watts et al., "Vasculitis in Clinical Medicine, 2010" Russo, Ricardo A. G.; Katsicas, María M. (2018). "Takayasu Arteritis ...
Weiss, PF (April 2012). "Pediatric vasculitis". Pediatric Clinics of North America. 59 (2): 407-423. doi:10.1016/j.pcl.2012.03. ...
See also vasculitis. Connective tissue diseases can have strong or weak inheritance risks, and can also be caused by ...
Kluger N, Jolly M, Guillot B (2008). "Tattoo-induced vasculitis". J Eur Acad Dermatol Venereol. 22 (5): 643-4. doi:10.1111/j. ... and vasculitis. Keratoacanthoma may also occur, which makes excision of the affected area mandatory. Eyeball tattoos carry ...
Vasculitis - Inflammation of blood vessels (veins & arteries) with a long list of causes. Aortitis - Inflammation of the aorta ... IgA vasculitis (IgAV; formerly known as Henoch-Schönlein purpura) - Affects small-sized vessels and produces palpable purpura ... Skin bulges indicating implanted devices: pacemaker, ICD, implantable loop recorder, vagus nerve stimulation Vasculitis rashes ... vasculitis) Skin exam Diabetic neuropathy Endocarditis signs: Janeway lesions, Osler's nodes, splinter hemorrhages Peripheral ...
Said, G (November 1997). "Necrotizing peripheral nerve vasculitis". Neurologic Clinics. 15 (4): 835-48. doi:10.1016/s0733-8619( ...
Some examples of systemic vasculitic disease are: IgA vasculitis, Hypocomplementemic urticarial vasculitis, polyarteritis ... Some patients with systemic vasculitis will have their multi-organ disease spread to the peripheral nervous system; this is ... "Vasculitis and peripheral neuropathy". Current Opinion in Rheumatology. 31 (1): 40-45. doi:10.1097/BOR.0000000000000559. ISSN ... Neuralgic amyotrophy Non-systemic skin/nerve vasculitis (for example, cutaneous PAN) There is an ongoing debate over this ...
... such as vasculitis due to cryoglobulinemia; on microscopy, the appearances are of a hypersensitivity vasculitis, and ... Cutaneous small-vessel vasculitis J. C. Jennette; R. J. Falk; P. A. Bacon; et al. (January 2013). "2012 Revised International ... The incidence of HSP in children is about 20 per 100,000 children per year, making it the most common vasculitis in children. ... Henoch-Schönlein purpura (HSP), also known as IgA vasculitis, is a disease of the skin, mucous membranes, and sometimes other ...
"Vasculitis" at Dorlands Medical Dictionary "The Johns Hopkins Vasculitis Center - Symptoms of Vasculitis". Archived from the ... Vasculitis is primarily caused by leukocyte migration and resultant damage. Although both occur in vasculitis, inflammation of ... Conditions with leucocytoclasis mainly include hypersensitivity vasculitis (also called leukocytoclastic vasculitis) and ... "Vasculitis therapy refines vasculitis mechanistic classification". Autoimmunity Reviews. 20 (6): 102829. doi:10.1016/j.autrev. ...
Vasculitis, also called Angiitis, is an inflammation of the blood vessels. Learn about symptoms and treatment. ... Vasculitis (Mayo Foundation for Medical Education and Research) Also in Spanish * Vasculitis in the Nervous System (National ... IgA vasculitis - Henoch-Schonlein purpura (Medical Encyclopedia) Also in Spanish * Necrotizing vasculitis (Medical Encyclopedia ... Symptoms of vasculitis can vary, but usually include fever, swelling and a general sense of feeling ill. The main goal of ...
Urticarial vasculitis may be divided into normocomplementemic and hypocomplementemic variants. ... Urticarial vasculitis is an eruption of erythematous wheals that clinically resemble urticaria but histologically show changes ... Urticarial vasculitis carries a good prognosis, with most occurrences resolving in months to years. Urticarial vasculitis ... The median age of urticarial vasculitis involvement is 43 years, with a range of 15-90 years. While urticarial vasculitis is ...
Without treatment, vasculitis can damage several organs and the nervous system. Learn more about these diseases and how to ... Vasculitis refers to conditions that cause inflammation of blood vessels. Arteries, veins, and capillaries throughout the body ... Primary vasculitis, which is vasculitis with no known cause, and secondary vasculitis, which occurred because of another ... Central nervous system vasculitis. Share on Pinterest. Central nervous system vasculitis can induce mental changes.. ...
Vasculitis is inflammation of the blood vessels. This inflammation can damage and narrow the blood vessels, causing a rash, a ... Vasculitis is inflammation of the blood vessels. This inflammation can damage and narrow the blood vessels, causing a rash, a ... Vasculitis can decrease blood supply to tissues or organs, causing blood clots, pain, tissue damage, and organ malfunction. ... Vasculitis has many possible causes, including allergic reactions and certain diseases, such as lupus. ...
Learn the symptoms, diagnosis, and treatment of ANCA vasculitis. ... ANCA vasculitis are a collection of autoimmune diseases that ... Urticarial vasculitis is a rare autoimmune disease. Learn the signs of urticarial vasculitis, what causes urticarial vasculitis ... Vasculitis Vasculitis (arteritis, angiitis) is a general term for a group of uncommon diseases which feature inflammation of ... Each form of vasculitis has its own characteristic pattern of symptoms. The diagnosis of vasculitis is definitively established ...
... mediated disorder characterized by a generalized vasculitis involving the small vessels of the skin, the gastrointestinal (GI) ... encoded search term (IgA Vasculitis (Henoch-Schonlein Purpura)) and IgA Vasculitis (Henoch-Schonlein Purpura) What to Read Next ... Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021. 12:771619. [QxMD MEDLINE Link]. [Full Text]. ... IgA Vasculitis (Henoch-Schonlein Purpura) Differential Diagnoses. Updated: Jun 28, 2023 * Author: Rajendra Bhimma, MBChB, MD, ...
Urticarial vasculitis (UV) is a potentially more serious, rare variant. The youngest reported case was 12 months of age. A ... Normocomplementaemic Urticarial Vasculitis in a 19-Month-Old Girl. Peter Williams. 1 ... Urticarial vasculitis (UV) is a potentially more serious, rare variant with a peak incidence in the fourth decade of life [1]. ... Urticarial vasculitis (UV) is a potentially more serious, rare variant. The youngest reported case was 12 months of age. A ...
... to Expand by 2025 - published on openPR.com ... Vasculitis of the kidneys may produce no symptoms at first. However, it can lead to a serious condition. Vasculitis can be ... ANCA Associated Diseases/Vasculitis Market Shares, Strategies and Forecast World … Vasculitis is an autoimmune disease in which ... Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a type of vasculitis. AAV is a group of three ...
Peter Grayson, the program studies systemic vasculitis by evaluating patients with the disease through comprehensive research ... The goal of the Vasculitis Translational Research Program (VTRP) is to discover factors that cause vasculitis and to develop ... The VTRP was established in 2013 to evaluate patients with known vasculitis or with clinical suspicion of vasculitis. Diseases ... drug-induced vasculitis, and monogenic vasculitis. Through these efforts, we have learned that a subset of neutrophils known as ...
The vasculitides are now viewed as chronic disease rather than fatal conditions. Their course is frequently characterized by ... Disease assessment and management of the vasculitides Baillieres Clin Rheumatol. 1997 May;11(2):423-46. doi: 10.1016/s0950-3579 ... The vasculitides are now viewed as chronic disease rather than fatal conditions. Their course is frequently characterized by ...
Here we identified three unrelated boys with perinatal-onset of neutrophilic cutaneous small vessel vasculitis and systemic ... the authors report a case series of three unrelated boys with perinatal-onset of neutrophilic cutaneous small vessel vasculitis ... 1: Discovery of de novo GOF mutations in LYN as cause of cutaneous vasculitis and liver fibrosis syndrome.. ... de Jesus, A.A., Chen, G., Yang, D. et al. Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver ...
... Tailored treatment may be a possibility for AAV in people with GPA or MPA. Posted on August 21, 2018 ... ANCA-associated vasculitis, Drug treatment Newly updated advice on the treatment of patients with AAV. Posted on August 18, ... ANCA-associated vasculitis, EULAR recommendationsTagged featuredLeave a comment Mycophenolate mofetil achieves remission in AAV ... Category: ANCA-associated vasculitis. Updated: Managing AAV. Posted on September 11, 2023. by skang ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...
Virtual Vasculitis Support Group Meeting Wednesday, December 20, 2023 at 2:30 PM CT Find your virtual, vasculitis support ... Virtual Vasculitis Support Group Meeting THURSDAY, December 21, 2023 @ 11:00 AM CT Find your virtual, vasculitis support system ... Virtual Vasculitis Support Group Meeting Wednesday, December 20, 2023 @ 1:00 PM CT Find your virtual, vasculitis support system ... Virtual Vasculitis Support Group Meeting Wednesday, December 20, 2023: 11:00 AM CT Find your virtual, vasculitis support system ...
The patients perspectives of the impact of vasculitis differ from the physicians ratings. Future outcome assessment in vascu ... Fatigue and reduced energy level are considered the most important disease burdens by patients with vasculitis; manifestations ... Outcome assessment in vasculitis primarily focuses on physician evaluations of disease activity and damage. Little is known ... Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective Arthritis Care Res ( ...
Learn more about the Vasculitis treatments offered at Mount Sinai, located in New York City. ... These conditions include drug-induced vasculitis, cryoglobulinemic vasculitis, and IgA vasculitis.. The diagnosis of vasculitis ... Vasculitis is a group of rare diseases that cause inflammation of the blood vessels. Vasculitis can be mild or severe, short- ... Large vessel vasculitis: Affects the aorta, the largest artery, and its major branches. Types of large-vessel vasculitis ...
Global epidemiology of vasculitis. *Mark. Watts, Richard A. ; Hatemi, Gulen ; Burns, Jane C. and Mohammad, Aladdin J. LU (2022 ... The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae ... The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae ... article{227a32a9-8b3c-46ba-a877-695404d142d5, abstract = {{,p,The many forms of vasculitis are characterized by inflammation of ...
... Jul 11, 2023. Erin Hunter, Assistant Editor ... It is an acute self-limiting inflammatory disorder associated with inflamed blood vessels (vasculitis), mainly of the coronary ...
We have discovered that the level rises when kidney vasculitis is active, and is not elevated in other causes of kidney disease ... The Vasculitis Foundation is a registered 501 (c) (3) non-profit organization. All contributions are 100% tax-deductible. ... Vasculitis Foundation. PO Box 28660. Kansas City, MO 64188. 1.816.436.8211 or 1.800.277.9474. ... Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals ...
M05.20 - Rheumatoid vasculitis with rheumatoid arthritis of unspecified site. SNOMEDCT:. 400054000 - Rheumatoid vasculitis ... Rheumatoid vasculitis Print Images (23) Contributors: Edward Li PhD, Art Papier MD, Susan Burgin MD. Other Resources UpToDate ... Rheumatoid vasculitis (RV) is a rare complication of rheumatoid arthritis (RA). RV usually occurs in the setting of prolonged ...
What does vasculitis have to do with vaccines?. If you do a simple Google search for vasculitis and vaccines, you will see ... What is vasculitis?. Vasculitis is considered a rare group of disorders caused by inflammation of blood vessels. It is a ... Learn how vasculitis is typically diagnosed:. In general, disorders caused by vasculitis are serious and need to be evaluated ... Vasculitis is a very dangerous disease. One of my friends had vasculitis. Well that all went well. Thanks to the doctors. ...
Braun, Gerald S.; Horster, Sophia; Wagner, Katrin S.; Ihrler, Stephan and Schmid, Holger (2007): Cryoglobulinaemic vasculitis: ... Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. An ... This review summarises the classification and clinical and therapeutic aspects of cryoglobulinaemic vasculitis and ...
Key Words: Idiopathic hypereosinophilic syndrome, Eosinophilia, Cerebral vasculitis, PDGFR molecular rearrangement, Imatinib ... Magnetic resonance imaging (MRI) confirmed the suspicion of CNS vasculitis (Figure 2). Re-test for ANCA produced the same ... A brain computed tomography (CT) scan revealed multiple lesions suspected for vasculitis of the central nervous system (CNS). ... Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib Paolo Fraticelli, ...
Here is a detailed overview of vasculitis - a common auto immune disease and its causes, symptoms, treatment options and ICD-10 ... Types of Vasculitis. Generally, physicians group vasculitis according to the size of the blood vessels affected. Most types of ... L95.9 Vasculitis limited to the skin, unspecified. Vasculitis complications may depend on the type and severity of the ... If vasculitis is the result of an allergic reaction, it does not require any specific treatment and may go away on its own. ...
... associated vasculitis, a rare but devastating disease of blood vessels. ... Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic ... The current standard of care for ANCA-associated vasculitis combines a 3-to 6-month course of daily cyclophosphamide plus ... After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis. Investigators have made a ...
Did the COVID-19 vaccine cause Ashton Kutcher to develop vasculitis that almost made him blind and deaf?! Find out what the ... Fact #3 : Vasculitis Is A Rare Autoimmune Disorder. Ashton Kutcher did not reveal what kind of vasculitis he had, but they all ... Fact #2 : Ashton Kutcher Had Vasculitis Before COVID-19. On August 9, 2022, he clarified that he actually had vasculitis three ... Like two years ago I had this weird, super rare form of vasculitis, that like knocked out my vision, it knocked out my hearing ...
Home / Shop / Imprints / Nova Medicine and Health / The Vasculitides. Volume 1: General Considerations and Systemic Vasculitis ... Systemic Vasculitis and the Kidney: ANCA-Associated Vasculitis and Glomerulonephritis. (Koyal Jain, Manish Saha and Ronald J. ... Rheumatoid Arthritis Vasculitis. Elana J. Bernstein and Robert F. Spiera, The Scleroderma, Vasculitis and Myositis Center, ... The Vasculitides. Volume 1: General Considerations and Systemic Vasculitis (Second Edition). $310.00. ...
Retinal vasculitis was reported in 45%-55% of the patients, but retinal artery occlusion secondary to vasculitis has been ... mongolitimonae Infection and Retinal Vasculitis. Volume 14, Number 4-April 2008. Article Views: 308. Data is collected weekly ... Fluorescein angiograph of the right eye of the patient showing retinal occlusive vasculitis with arteriolar leakage at late ... Fluorescein angiograph of the right eye of the patient showing retinal occlusive vasculitis with arteriolar leakage at late ...
  • Vasculitis is a group of disorders that destroy blood vessels by inflammation. (wikipedia.org)
  • For example, ICD-10 classifies "vasculitis limited to skin" with skin conditions (under "L"), and "necrotizing vasculopathies" (corresponding to systemic vasculitis) with musculoskeletal system and connective tissue conditions (under "M"). Arteritis/phlebitis on their own are classified with circulatory conditions (under "I"). Type or size of the blood vessels that they predominantly affect. (wikipedia.org)
  • Vasculitis is an inflammation of the blood vessels. (medlineplus.gov)
  • Vasculitis refers to a large group of diseases, also known as angiitis, that damage blood vessels by causing inflammation. (medicalnewstoday.com)
  • Vasculitis means inflammation of the blood vessels. (medicalnewstoday.com)
  • Signs and symptoms of vasculitis vary depending on which blood vessels are affected, and which organs are damaged, if any. (medicalnewstoday.com)
  • Vasculitis is a family of rare diseases defined by inflammation in blood vessels. (nih.gov)
  • Vasculitis is a group of rare diseases that cause inflammation of the blood vessels. (mountsinai.org)
  • The many forms of vasculitis are characterized by inflammation of blood vessels, leading to potentially long-term sequelae including vision loss, aneurysm formation and kidney failure. (lu.se)
  • It is an acute self-limiting inflammatory disorder associated with inflamed blood vessels (vasculitis), mainly of the coronary arteries, which largely impacts children aged 5 years and younger. (pharmacytimes.com)
  • A general term for a large group of diseases, vasculitis is a condition that causes inflammation and narrowing of the blood vessels (arteries, veins and capillaries) that carry blood to and from the heart and the body's organs. (outsourcestrategies.com)
  • Also called angiitis or arteritis, vasculitis can cause alterations in the walls of the blood vessels such as weakening, scarring, narrowing and thickening that cause them to close entirely. (outsourcestrategies.com)
  • As mentioned above, vasculitis occurs when the body's immune system mistakenly attacks its blood vessels. (outsourcestrategies.com)
  • Generally, physicians group vasculitis according to the size of the blood vessels affected. (outsourcestrategies.com)
  • Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. (nih.gov)
  • Patients with ANCA-associated vasculitis make antibodies that attack immune cells called neutrophils, causing inflammation in small-to medium-sized blood vessels. (nih.gov)
  • On August 8, 2022, Ashton Kutcher revealed on an episode of National Geographic's Running Wild with Bear Grylls: The Challenge that he was "lucky to be alive" after dealing with a rare form of vasculitis - inflammation of the blood vessels. (rojakpot.com)
  • Ashton Kutcher did not reveal what kind of vasculitis he had, but they all cause inflammation of the blood vessels. (rojakpot.com)
  • Leukocytoclastic Vasculitis (LCV) Introduction Vasculitis is defined as an inflammation of the blood vessels, this inflammation may present inside or may surround the blood vessels whereas Leukocytoclastic vasculitis (LCV) is an inflammatory condition of the blood vessels particularly the small ones which are characterized by palpable purpura (red and purple discolored spots on the skin). (planetayurveda.com)
  • The classification of vasculitides depends mainly on the size and type of blood vessels involved. (printo.it)
  • Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. (clickpress.com)
  • Vasculitis is defined as inflammation of the wall of blood vessels. (scielo.org.za)
  • Lymphangitis (inflammation of lymphatic vessels) is sometimes considered a type of vasculitis. (wikipedia.org)
  • Although both occur in vasculitis, inflammation of veins (phlebitis) or arteries (arteritis) on their own are separate entities. (wikipedia.org)
  • In pediatric patients, varicella inflammation may be followed by vasculitis of intracranial vessels. (wikipedia.org)
  • Antineutrophilic cytoplasmic antibody (ANCA)-linked vasculitides are a diverse collection of uncommon autoimmune diseases that result in blood vessel inflammation with varying symptoms. (medicinenet.com)
  • Vascular imaging including FDG-PET (left) and magnetic resonance angiography are useful to evaluate vascular inflammation and damage in patients with large-vessel vasculitis. (nih.gov)
  • We discovered that the majority of patients with large-vessel vasculitis have evidence of ongoing vascular inflammation by FDG-PET scans during periods of apparent clinical remission and that the degree of vascular inflammation seen during clinical remission predicts future relapse. (nih.gov)
  • Here we identified three unrelated boys with perinatal-onset of neutrophilic cutaneous small vessel vasculitis and systemic inflammation. (nature.com)
  • all presented with systemic inflammation and recurrent neutrophilic small vessel vasculitis. (nature.com)
  • How vasculitis presents itself depends upon which tissues, organs or systems are affected, and to which degree they are affected by the impaired blood flow resulting from inflammation. (sanevax.org)
  • Systemic and nervous system vasculitides are a heterogeneous group of related disorders, each characterized by vascular inflammation such that they have the potential to cause serious morbidity and mortality if unrecognized and therefore untreated. (novapublishers.com)
  • We operationally define central nervous system vasculitis (CNSV) as any inflammatory vasculopathy producing nonatheromatous inflammation of intracranial vessels either directly (eg, primary CNS vasculitis) or indirectly via inflammation of CNS parenchyma with secondary vascular involvement (eg, as seen with infections, tumors, and certain autoimmune conditions). (ajnr.org)
  • Vasculitis is inflammation of the blood vessel walls. (printo.it)
  • Widespread (systemic) vasculitis is usually accompanied by extensive release of inflammatory molecules, causing general symptoms like fever, malaise, as well as abnormal laboratory tests detecting inflammation: erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP). (printo.it)
  • Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? (clinexprheumatol.org)
  • Granulomatosis with Polyangiitis (GPA) Granulomatosis with polyangiitis is characterized by necrotizing granulomatous inflammation, small- and medium-sized vessel vasculitis, and focal necrotizing glomerulonephritis, often with crescent. (merckmanuals.com)
  • the vessel inflammation (true vasculitis) is only part of the pathophysiology and there is predominant parenchymal inflammation in a characteristic pattern that involves specific organs. (merckmanuals.com)
  • Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of diseases (granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis and microscopic polyangiitis), characterized by destruction and inflammation of small vessels. (nih.gov)
  • Systemic vasculitis affect all populations and every nationality and walk-of-life, from childhood to older age. (novapublishers.com)
  • This is the first book in the set, covering general considerations and systemic vasculitis. (novapublishers.com)
  • Rectal biopsy in the diagnosis of systemic vasculitis. (bmj.com)
  • It is useful as a "blind" biopsy site in the diagnosis of systemic vasculitis, especially that complicating RA. (bmj.com)
  • If skin involvement is secondary to a systemic vasculitis, symptoms may also include fever, arthralgias, other organ involvement, or a combination. (msdmanuals.com)
  • Apart from the arteritis/phlebitis distinction mentioned above, vasculitis is often classified by the caliber of the vessel affected. (wikipedia.org)
  • According to the size of the vessel affected, vasculitis can be classified into: Large vessel: Takayasu's arteritis, Temporal arteritis Medium vessel: Buerger's disease, Kawasaki disease, Polyarteritis nodosa Small vessel: Behçet's syndrome, Eosinophilic granulomatosis with polyangiitis, Cutaneous vasculitis, granulomatosis with polyangiitis, Henoch-Schönlein purpura, and microscopic polyangiitis. (wikipedia.org)
  • The pathophysiology of urticarial vasculitis is similar to other forms of cutaneous small vessel leukocytoclastic vasculitis. (medscape.com)
  • Vasculitis can affect any blood vessel anywhere in the body. (medicalnewstoday.com)
  • Our group has employed advanced molecular imaging techniques in patients with large-vessel vasculitis to study whether serial imaging has diagnostic and prognostic value in addition to monitoring utility. (nih.gov)
  • Types of large-vessel vasculitis include giant cell arteritis, Takayasu arteritis, aortitis in Cogan's syndrome. (mountsinai.org)
  • Types of medium-vessel vasculitis are Kawasaki disease and polyarteritis nodosa. (mountsinai.org)
  • Medium vessel - This includes Buerger's disease, cutaneous vasculitis, Kawasaki disease, and polyarteritis nodosa. (outsourcestrategies.com)
  • 1.4 What happens to the blood vessel in vasculitis? (printo.it)
  • Vasculitis classification in children is based on the size of the blood vessel involved. (printo.it)
  • Large vessel vasculitis, like Takayasu arteritis, affects the aorta and its major branches. (printo.it)
  • Medium vessel vasculitis typically affects arteries supplying the kidneys, bowels, brain or heart (e.g. polyarteritis nodosa, Kawasaki disease). (printo.it)
  • This report specifically covers large vessel vasculitis (LLV), Kawasaki disease (KD), antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), and Behcet's disease (BD). (clickpress.com)
  • Skin biopsy revealed small and intermediate vessel vasculitis. (scielo.org.za)
  • [6] Takayasu's arteritis is an example of a large-vessel vasculitis in childhood, whereas Kawasaki disease and polyarteritis nodosa are examples of medium-vessel vasculitis disorders. (scielo.org.za)
  • AAV encompasses three small-vessel vasculitides in which clinical features result from focal necrotizing lesions in vessels and organs and include alveolar hemorrhage, acute renal failure, and purpuric rashes. (clinicaladvisor.com)
  • Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis? (clinexprheumatol.org)
  • Some forms of vasculitis are characterized by giant cells in the vessel wall. (merckmanuals.com)
  • Leukocytoclastic vasculitis is a histopathologic term used to describe findings in small-vessel vasculitis. (merckmanuals.com)
  • Several novel insights recently reported by the Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group get the rheumatology community closer to a core set of domains for large vessel vasculitis and will be used to establish outcome measures for use in clinical trials. (the-rheumatologist.org)
  • 1 These insights address definitions of subclinical disease activity in large vessel vasculitis and take into account patient perspectives regarding the aspects of therapy response important to them, such as pain and fatigue . (the-rheumatologist.org)
  • The development of the definitions will provide a standardized approach-a tailored tool specifically designed for [large vessel vasculitis]," says Sibel Zehra Aydin, MD, a rheumatologist and associate professor of rheumatology at the University of Ottawa in Ontario, Canada. (the-rheumatologist.org)
  • The ongoing work of this OMERACT group has been to employ a data-driven approach to developing a core set of domains to shape standardized outcome measures for clinical trials of large vessel vasculitis treatments. (the-rheumatologist.org)
  • The comprehensive review of the literature conducted by this working group several years ago demonstrated a lack of standardized outcome measures for large vessel vasculitis. (the-rheumatologist.org)
  • She also notes randomized controlled trials conducted for treatments targeting large vessel vasculitis diseases, such as Takayasu's arteritis and giant cell arteritis , have usually based definitions of relapse and remission on the presence or absence of signs and symptoms and/or acute phase reactants. (the-rheumatologist.org)
  • In 2016, the OMERACT group proposed a preliminary set of core domains for use in clinical trials of large vessel vasculitis, with additional disease-specific elements, such as pain and fatigue. (the-rheumatologist.org)
  • Published data and clinical advances, such as PET (positron-emission tomography), are making it easier to identify large vessel vasculitis patients who appear to be in clinical remission but who still demonstrate disease activity. (the-rheumatologist.org)
  • 5,6 This ability is leading rheumatologists to discover subcategories of large vessel vasculitis, notes Antoine Sreih, MD, a rheumatologist and assistant professor of clinical medicine at Penn Medicine in Philadelphia. (the-rheumatologist.org)
  • Dr. Sreih specializes in caring for large vessel vasculitis patients and is a member of the OMERACT working group. (the-rheumatologist.org)
  • CSVV sometimes refers to small-vessel vasculitis of unknown cause (also called idiopathic cutaneous small-vessel vasculitis). (msdmanuals.com)
  • Hypersensitivity vasculitis, which is usually represented histopathologically as leukocytoclastic vasculitis (LCV), is a term commonly used to denote a small-vessel vasculitis. (medscape.com)
  • A 2014 population-based study in Minnesota found the incidence of cutaneous leukocytoclastic vasculitis in adults (including IgA vasculitis as well as other types of small-vessel vasculitis) to be at 45 cases per million. (medscape.com)
  • Henoch-Schönlein purpura (HSP), a small-vessel vasculitis characterized by deposition of immunoglobulin A (IgA) immune complexes, reportedly has an incidence of 14 cases per million people per year. (medscape.com)
  • HSP is a specific small-vessel vasculitis associated with the presence of vascular IgA deposition. (medscape.com)
  • Urticarial vasculitis is an eruption of erythematous wheals that clinically resemble urticaria but histologically show changes of leukocytoclastic vasculitis . (medscape.com)
  • Leukocytoclastic vasculitis displayed an incidence of 45 cases per million population from a study conducted in Olmsted County, Minnesota. (medscape.com)
  • Henoch-Schönlein purpura, granulomatosis with polyangiitis or GPA, eosinophilic granulomatosis with polyangiitis or EGPA, previously referred to as Churg-Strauss syndrome), cutaneous leukocytoclastic vasculitis, microscopic polyangiitis). (printo.it)
  • Diseases of interest include Takayasu's arteritis (TAK), relapsing polychondritis (RP), giant cell arteritis (GCA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA), and polyarteritis nodosa (PAN) among other types of vasculitis. (nih.gov)
  • The study included 41 patients (78 eyes) with 5 types of primary vasculitis, ie, Takayasu's arteritis, giant cell arteritis, Buerger's disease, granulomatosis with polyangiitis, and polyarteritis nodosa. (ophthalmologytimes.com)
  • Do Vaccines Cause Vasculitis or Polyarteritis Nodosa? (vaccinesafety.edu)
  • The most common finding was a necrotising vasculitis of small arteries, indistinguishable from that seen in polyarteritis nodosa (PAN). (bmj.com)
  • In these cases, the antibody found is sometimes used in classification, as in ANCA-associated vasculitides. (wikipedia.org)
  • What Are Symptoms of ANCA Vasculitis? (medicinenet.com)
  • ANCA vasculitis is a collection of autoimmune diseases with varying symptoms. (medicinenet.com)
  • Antineutrophil cytoplasmic antibody (ANCA) vasculitis can result in various symptoms depending on the organ or body part affected. (medicinenet.com)
  • We still don't know why patients with ANCA vasculitis experience damage to different organs or body parts. (medicinenet.com)
  • What is ANCA vasculitis? (medicinenet.com)
  • Drug-induced vasculitis and renal-limited vasculitis are other conditions linked to ANCA. (medicinenet.com)
  • The diagnosis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is based on the presence of ANCA, clinical symptoms, and a biopsy of the frequently affected organs such as the kidneys and nasal mucosa or the lungs (which are infrequently affected). (medicinenet.com)
  • What is the treatment of ANCA vasculitis? (medicinenet.com)
  • Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a type of vasculitis. (openpr.com)
  • Rise in incidences of metabolic disorders and circulatory diseases and changing lifestyle are likely to increase the prevelance of this disease, driving the ANCA Associated Diseases/Vasculitis Market. (openpr.com)
  • However, lack of awareness is likely to restrain the ANCA Associated Diseases/Vasculitis market in the near future. (openpr.com)
  • The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be segmented based on route of administration of drug, distribution channel, and region. (openpr.com)
  • Based on the route of administration of drug, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be classified into parenteral, oral, nasal, and topical. (openpr.com)
  • The parenteral route segment accounts for a dominant share of the ANCA Associated Diseases/Vasculitis market due to higher availability and stability of the drug in the injectable form and immediate response. (openpr.com)
  • In terms of distribution channel, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market can be categorized into retail store, pharmacy, and e-commerce. (openpr.com)
  • Based on region, the antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. (openpr.com)
  • North America dominates the ANCA Associated Diseases/Vasculitis market owing to increased awareness and high incidences of circulatory diseases and changing lifestyle. (openpr.com)
  • In addition, Asia Pacific is a rapidly expanding region of the Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment market because of changing lifestyle, rise in population following an urban lifestyle, and significant expansion in the economy of this region. (openpr.com)
  • Some of the key players engaged in developing vasculitis therapeutics ANCA Associated Diseases/Vasculitismarket are Novartis AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., RNL BIO Co., Ltd., Human Genome Sciences, Inc.¸ Johnson & Johnson's, and Genentech, Inc. among others. (openpr.com)
  • This name of this disease is often shortened to ANCA-associated vasculitis, or AAV. (bmj.com)
  • Introduction ANCA-associated vasculitis (shortened to AAV), is a rare group of diseases that are very serious, and can be life-threatening. (bmj.com)
  • INTRODUCTION A central focus of newly updated recommendations on treating ANCA-associated vasculitis (AAV) is shared decision-making between patients and doctors. (bmj.com)
  • The current standard of care for ANCA-associated vasculitis combines a 3-to 6-month course of daily cyclophosphamide plus steroids, followed by long-term daily azathioprine (AZA) plus steroids. (nih.gov)
  • In search of an alternative therapy for patients with ANCA-associated vasculitis, ITN investigators turned to rituximab, a synthetic antibody that selectively reduces the number of B cells circulating in the blood. (nih.gov)
  • According to the ITN investigators, the study has successfully demonstrated that rituximab provided comparable benefits as standard therapy for ANCA-associated vasculitis. (nih.gov)
  • The first edition of The Vasculitides, published in 2014, met the urgent need for a clear, concise, and reliable textbook regarding the epidemiology, pathogenesis, clinical presentation, laboratory evaluation and management of these disorders, assembling participants of the 16th International Vasculitis and ANCA Workshop in Paris, France. (novapublishers.com)
  • Participants of the 19th International Vasculitis & ANCA Workshop will gather in April 2019 at the University of Pennsylvania for an exceptional venue to share translational scientific discoveries, data from clinical trials, and advances in the clinical assessment, pathophysiology, genetic biomarkers, standard-of-care, and novel therapies of vasculitis. (novapublishers.com)
  • Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. (bmj.com)
  • The long-term survival of patients with ANCA associated vasculitis treated with current regimens is uncertain. (bmj.com)
  • Objective To describe the long-term patient survival and possible prognostic factors at presentation in an international, multicentre, prospectively recruited representative patient cohort who were treated according to strictly defined protocols at presentation and included the full spectrum of ANCA-associated vasculitis disease. (bmj.com)
  • Trial eligibility was defined by disease severity and extent, covered the spectrum of severity of ANCA-associated vasculitis and used consistent diagnostic criteria. (bmj.com)
  • Conclusion Patients with ANCA-associated vasculitis treated with conventional regimens are at increased risk of death compared with an age- and sex-matched population. (bmj.com)
  • This patient developed propylthiouracil-induced ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis (AAV), a condition associated with significant morbidity and mortality. (clinicaladvisor.com)
  • Hematuria is common in myeloperoxidase anti-neutrophil cytoplasmic antibody associated vasculitis (ANCA-MPO). (springer.com)
  • Therefore, the main aim of this study was to assess the predictive yield of urinary isomorphic red blood cells for disease severity and renal outcomes in patients with ANCA-MPO associated vasculitis. (springer.com)
  • A total of 191 patients with ANCA-MPO associated vasculitis with hematuria were retrospectively selected and were divided into two groups (with isomorphic red blood cells versus dysmorphic red blood cells) according to the percentage of isomorphic red blood cells on urinary sediment analysis. (springer.com)
  • In this respect, urinary isomorphic red blood cells could be viewed as a promising biomarker of ANCA_MPO vasculitis severity and progression. (springer.com)
  • Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (2016) ANCA-associated vasculitis-clinical utility of using ANCA specificity to classify patients. (springer.com)
  • Geetha D, Jefferson JA (2020) ANCA-associated vasculitis: core curriculum 2020. (springer.com)
  • In ANCA-mediated vasculitis, intracellular proteins from neutrophils become expressed on the cell surface, leading to formation of antibodies (ANCA). (medscape.com)
  • However, when a study in the United Kingdom used consistent criteria restricted to patients diagnosed with vasculitis by biopsy and with urticarial lesions of more than 3 months duration, 2.1% of 1310 patients with urticaria were found to have urticarial vasculitis. (medscape.com)
  • The diagnosis of vasculitis requires imaging tests, such as computed tomography, angiography, and magnetic resonance imaging and often a tissue sample (biopsy). (mountsinai.org)
  • We report a case of biopsy proven vasculitis, presenting as mononeuritis multiplex, following influenza vaccination. (sanevax.org)
  • Diagnosis of Vasculitis made from biopsy of a lesion. (abchomeopathy.com)
  • Vasculitis was reported as the cause of death on postmortem biopsy. (scielo.org.za)
  • In the immediately preceding ad-mission, wound culture had shown Methicillin-resistant Staphylococcus aureus (MRSA) and pseudomonas, and skin biopsy confirmed vasculitis with immune deposits of IgM, IgG, and C3. (bcmj.org)
  • An adequate biopsy is positive in 40% of patients with clinical vasculitis and RA but was only positive in one of a control series of 46 RA patients with no clinical vasculitis. (bmj.com)
  • Serial sections of the entire biopsy may be required to reveal the vasculitis which is often focal in nature. (bmj.com)
  • In both adults and children, Henoch-Schönlein purpura (HSP) may present in a clinically identical fashion to hypersensitivity vasculitis, and biopsy with direct immunofluorescence is typically needed to distinguish the two. (medscape.com)
  • An update from Apellis reports 10 confirmed events of retinal vasculitis and 2 suspected events associated with pegcetacoplan injection for geographic atrophy. (consultantlive.com)
  • Apellis Pharmaceuticals has shared an update on the launch of pegcetacoplan injection (SYFOVRE) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) , including an update on the events of retinal vasculitis associated with the therapy. (consultantlive.com)
  • At that time, the company provided an update on injection kits with the use of pegcetacoplan injection and confirmed 8 events of retinal vasculitis. (consultantlive.com)
  • Estimates suggest the real-world rate of retinal vasculitis is rare at 0.01% per injection. (consultantlive.com)
  • To this date, there have been 10 confirmed events of retinal vasculitis (7 occlusive 3 non-occlusive) and 2 suspected events. (consultantlive.com)
  • Of the 2 events previously considered "suspected", the company confirmed 1 event while the other was adjudicated to not be retinal vasculitis. (consultantlive.com)
  • Within the confirmed retinal vasculitis events, 6 patients have recovered vision either fully or partially, while 3 patients have severe vision impairment unlikely to be resolved, and 1 outcome is still pending. (consultantlive.com)
  • All identified reported adverse events are submitted by Apellis to the FDA, and the company is in communication with the American Society of Retina Specialists (ASRS) on these reported cases of retinal vasculitis. (consultantlive.com)
  • I think it's important to know that there is a risk of retinal vasculitis or occlusive vasculitis when using pegcetacoplan, so it's important to consent your patients to the risk," Dilsher Dhoot, MD of California Retina Consultants told HCPLive at the ASRS 41st Annual Meeting. (consultantlive.com)
  • Iapoce C. APELLIS shares update on Pegcetacoplan injection kits, retinal vasculitis events. (consultantlive.com)
  • https://www.hcplive.com/view/apellis-update-pegcetacoplan-injection-kits-retinal-vasculitis-events. (consultantlive.com)
  • Treatment for vasculitis depends on several factors, including what type of vasculitis the person has, the severity of their symptoms, their age, and their general health. (medicalnewstoday.com)
  • This is the lay version of the EULAR recommendations for the management of people with a type of vasculitis associated with an antibody called antineutrophil cytoplasmic antibody. (bmj.com)
  • Symptoms of the condition depend on the type of vasculitis a person suffers from and the part of the organ system affected. (outsourcestrategies.com)
  • The signs and symptoms vary and can range from mild to life-threatening depending on the type of vasculitis, the specific affected area and the severity of the condition. (outsourcestrategies.com)
  • Henoch-Schonlein purpura (HSP) is a form of vasculitis and associated with palpable purpura. (hindawi.com)
  • Right after Ashton Kutcher revealed that he suffered a super rare form of vasculitis that almost made him blind and deaf, anti-vaccination activists immediately claimed that it was caused by COVID-19 vaccines. (rojakpot.com)
  • Like two years ago I had this weird, super rare form of vasculitis, that like knocked out my vision, it knocked out my hearing, it knocked out like all my equilibrium. (rojakpot.com)
  • One exception is a very recently described form of vasculitis, called "DADA2", but this is very rare. (printo.it)
  • [ 1 ] In this form of vasculitis, circulating antigens in the body (produced by factors such as medications, infections, and neoplasms) induce antibody formation. (medscape.com)
  • Clinical studies with immunosuppressive drugs targeting specific cytokines and cells can also be used to understand the heterogeneous immunopathogenic mechanisms of vasculitis and support a mechanistic immunological classification. (wikipedia.org)
  • The identification of factors that cause vasculitis and the discovery of biomarkers that can predict clinical outcomes and guide patient-specific therapeutic decisions is the major focus of the VTRP. (nih.gov)
  • The VTRP was established in 2013 to evaluate patients with known vasculitis or with clinical suspicion of vasculitis. (nih.gov)
  • Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives. (vasculitisfoundation.org)
  • This review summarises the classification and clinical and therapeutic aspects of cryoglobulinaemic vasculitis and glomerulonephritis. (uni-muenchen.de)
  • The clinical spectrum of primary renal vasculitis. (medscape.com)
  • Myeloperoxidase-anti-neutrophil cytoplasmic antibody associated vasculitis patients with predominant urinary isomorphic red blood cells at diagnosis had more severe clinical manifestations and a higher risk of poor renal outcomes. (springer.com)
  • Clinical diagnosis of levamisole-induced vasculitis was made and antibiotics were discontinued. (bcmj.org)
  • Since the IOM report, a 2015 randomized trial found that influenza vaccine was safe for patients in remission with anti-neutrophil cytoplasmic antibody-associated vasculitis 4 , and a 2016 prospective observational study found that vaccinations had no significant clinical impact on patients with systemic necrotizing vasculitis 5 . (vaccinesafety.edu)
  • Although much less common than giant cell arteritis, the different forms of antineutrophil cytoplasmic antibody-associated vasculitis are being increasingly recognized in most populations and occur more frequently with increasing age. (lu.se)
  • While urticarial vasculitis is primarily a disease of middle-aged adults, it can be seen in persons of any age. (medscape.com)
  • Urticarial vasculitis associated with hypocomplementemia is associated with a greater incidence of coexisting disease (ie, angioedema, connective-tissue disease [primarily SLE], chronic obstructive pulmonary disease ). (medscape.com)
  • Vasculitis is an autoimmune disease in which the body comes under attack from its own immune system, especially neutrophils, and in some cases it is also caused by reactions to medicines. (openpr.com)
  • Although most patients with vasculitis achieve remission with treatment, the majority of patients experience one or more recurrences of the disease. (nih.gov)
  • The vasculitides are now viewed as chronic disease rather than fatal conditions. (nih.gov)
  • We characterize the role of increased Lyn kinase activity in neutrophils, endothelial cells and lesional liver biopsies and utilized an iPSC-derived endothelial cell platform for disease modeling of neutrophilic vasculitis and to screen and evaluate drug efficacy. (nature.com)
  • To assess patients' self-estimates of the burden of disease in vasculitis and to compare data across patient populations from the US, Germany, and the UK. (nih.gov)
  • Outcome assessment in vasculitis primarily focuses on physician evaluations of disease activity and damage. (nih.gov)
  • By contrast, Kawasaki disease mainly occurs in children aged under 5 years and is most common in children of Asian ancestry, and IgA vasculitis occurs in children and adolescents. (lu.se)
  • We have discovered that the level rises when kidney vasculitis is active, and is not elevated in other causes of kidney disease. (vasculitisfoundation.org)
  • AshtonKutcher says he has #Vasculitis that is an auto immune disease. (rojakpot.com)
  • Vasculitis is an autoimmune disease that can be triggered by infections, other autoimmune diseases, and certain medications. (rojakpot.com)
  • Kawasaki Disease Kawasaki disease is a vasculitis, sometimes involving the coronary arteries, that tends to occur in infants and children between the ages of 1 year and 8 years. (merckmanuals.com)
  • Hypersensitivity vasculitis may present clinically as cutaneous disease only or it may be a cutaneous manifestation of systemic disease. (medscape.com)
  • A diagnosis of vasculitis limited to the skin requires a complete history and physical examination. (msdmanuals.com)
  • These are: Granulomatosis with polyangiitis Eosinophilic granulomatosis with polyangiitis Microscopic polyangiitis Laboratory tests of blood or body fluids are performed for patients with active vasculitis. (wikipedia.org)
  • There are two main forms of this type of autoimmune vasculitis - microscopic polyangitis and Wegener's granulomatosis. (nih.gov)
  • 2.1 What are the types of vasculitis? (printo.it)
  • They pointed out that while ocular manifestations have been reported in association with various types of vasculitis, there seems to be no routine ophthalmologic examinations for patients with those diseases. (ophthalmologytimes.com)
  • Vasculitis can affect arteries, veins and capillaries. (medlineplus.gov)
  • Vasculitis is caused by leukocyte migration and can affect arteries and veins in the body. (openpr.com)
  • Carotid angiograms displayed segmentary narrowing of intracranial arteries as previously described in benign cerebral vasculitis. (bmj.com)
  • Vasculitis has a number of potential causes including infections and immunologic diseases. (medicalnewstoday.com)
  • Vasculitis has many possible causes, including allergic reactions and certain diseases, such as lupus. (healthlinkbc.ca)
  • The goal of the Vasculitis Translational Research Program (VTRP) is to discover factors that cause vasculitis and to develop novel ways for physicians to diagnose and monitor these diseases more effectively. (nih.gov)
  • Central nervous system vasculitides are elusive diseases that are challenging to diagnose because brain biopsies have high false-negative rates. (ajnr.org)
  • Vasculitides include a wide group of diseases. (printo.it)
  • Some of the acute primary vasculitides are quite common paediatric diseases (e.g. (printo.it)
  • A 2020 systematic review and meta-analysis found no association between HPV vaccines and many autoimmune or other rare diseases (including vasculitis) 14 . (vaccinesafety.edu)
  • On August 9, 2022, he clarified that he actually had vasculitis three years ago, in 2019 - before the COVID-19 pandemic, and over a year before the COVID-19 vaccines were approved. (rojakpot.com)
  • Urticarial vasculitis is a type III hypersensitivity reaction in which antigen-antibody complexes are deposited in the vascular lumina. (medscape.com)
  • Patients with hypocomplementemic urticarial vasculitis are more likely to show autoantibodies to C1q and vascular endothelial cells. (medscape.com)
  • The etiology of urticarial vasculitis has not been elucidated. (medscape.com)
  • The exact frequency of urticarial vasculitis is not known in the United States or worldwide. (medscape.com)
  • The male-to-female ratio for urticarial vasculitis is 1:2. (medscape.com)
  • The median age of urticarial vasculitis involvement is 43 years, with a range of 15-90 years. (medscape.com)
  • Urticarial vasculitis tends to become a chronic condition and patients should be educated about its course. (medscape.com)
  • Urticarial vasculitis carries a good prognosis, with most occurrences resolving in months to years. (medscape.com)
  • Since urticarial vasculitis may be chronic, educate patients about its course. (medscape.com)
  • Oi M, Satoh T, Yokozeki H, Nishioka K. Infectious urticaria with purpura: a mild subtype of urticarial vasculitis? (medscape.com)
  • Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab. (medscape.com)
  • Urticarial vasculitis (UV) is a potentially more serious, rare variant. (hindawi.com)
  • Urticarial vasculitis (UV) is a potentially more serious, rare variant with a peak incidence in the fourth decade of life [ 1 ]. (hindawi.com)
  • Symptoms of vasculitis can vary, but usually include fever, swelling and a general sense of feeling ill. (medlineplus.gov)
  • Symptoms of vasculitis can include fever , tiredness , and joint pain. (medicalnewstoday.com)
  • Vasculitis can cause symptoms such as fever or night sweats , body aches, joint and muscle discomfort, decreased appetite , and weight loss . (medicinenet.com)
  • The symptoms of vasculitis include shortness of breath, reddish spots on the skin, numbness, and sores. (openpr.com)
  • Vasculitis of the kidneys may produce no symptoms at first. (openpr.com)
  • Churg-Strauss vasculitis [4] can have symptoms similar to asthma because of lung involvement. (sanevax.org)
  • The symptoms listed above are by no means an exhaustive list, but it does give you some idea of the various possible manifestations and how easily vasculitis can be mistaken for a multitude of other disorders. (sanevax.org)
  • The investigators concluded, "Conducting routine ophthalmologic examinations in patients diagnosed with vasculitis to assess the retina and choroid by measuring parameters like the choroidal thickness, the choroidal vascularity index, area and perimeter of the foveal avascular zone, and the circularity index could be beneficial, because it may detect pathological changes before any ocular symptoms alarm the patients. (ophthalmologytimes.com)
  • When Do Symptoms of Anti-neutrophil cytoplasmic antibody-associated vasculitis Begin? (nih.gov)
  • Secondary vasculitis may be triggered by an infection, a drug, or a toxin or may occur as part of another inflammatory disorder or cancer. (merckmanuals.com)
  • Vasculitis can decrease blood supply to tissues or organs, causing blood clots, pain, tissue damage, and organ malfunction. (healthlinkbc.ca)
  • Treatment options for this condition depend on what factors are causing vasculitis and which organs get affected. (outsourcestrategies.com)
  • Cutaneous Vasculitis Cutaneous vasculitis refers to vasculitis affecting small- or medium-sized vessels in the skin and subcutaneous tissue but not the internal organs. (merckmanuals.com)
  • This term describes vasculitis that affects the skin but not the internal organs. (msdmanuals.com)
  • The internal organs most commonly affected in hypersensitivity vasculitis are the joints, gastrointestinal tract, and kidneys. (medscape.com)
  • 15 ml/min, advancing age, higher Birmingham Vasculitis Activity Score, lower haemoglobin and higher white cell count were significant negative prognostic factors for patient survival. (bmj.com)
  • Cutaneous vasculitis may be limited to the skin, or may be a component of a systemic primary or secondary vasculitic disorder. (msdmanuals.com)
  • Oni L, Sampath S. Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps. (medscape.com)
  • UV is part of a spectrum from urticaria to vasculitis and must be differentiated from other causes of purpura and investigated with urine analysis and complement testing. (hindawi.com)
  • Cutaneous vasculitis [7] may cause petechiae (small red dots), purpura, urticaria (hives), bruising, or ulcers of the skin. (sanevax.org)
  • Vasculitis affecting the small vessels of the skin (eg, arterioles, capillaries, postcapillary venules) tends to cause lesions such as purpura, petechiae, and possibly shallow ulcers. (msdmanuals.com)
  • Vasculitis can be acute and short-term or chronic and long-term. (medicalnewstoday.com)
  • Hypersensitivity vasculitis may be acute and self-limited, recurrent, or chronic. (medscape.com)
  • The prognosis of patients with cutaneous vasculitis depends on the underlying syndrome and the presence of end-organ dysfunction. (medscape.com)
  • Virtual Vasculitis Support Group Meeting THURSDAY, December 21, 2023 @ 11:00 AM CT Find your virtual, vasculitis support system today! (vasculitisfoundation.org)
  • Virtual Vasculitis Support Group Meeting Wednesday, December 20, 2023 at 2:30 PM CT Find your virtual, vasculitis support system today! (vasculitisfoundation.org)
  • Fluorescein angiograph of the right eye of the patient showing retinal occlusive vasculitis with arteriolar leakage at late phase. (cdc.gov)
  • However, hypersensitivity vasculitis is sometimes used to refer to CSVV caused by a known drug or infection. (msdmanuals.com)
  • Overall, hypersensitivity vasculitis has a favorable prognosis, particularly when no internal involvement is present. (medscape.com)
  • Hypersensitivity vasculitis is thought to be mediated by immune complex deposition. (medscape.com)
  • Overall, however, the exact mechanisms causing hypersensitivity vasculitis remain to be elucidated. (medscape.com)
  • The incidence of hypersensitivity vasculitis is unknown, but the condition is presumed to be relatively rare. (medscape.com)
  • Several studies from Spain have been conducted on hypersensitivity vasculitis. (medscape.com)
  • Hypersensitivity vasculitis is reported most often in the white population, but epidemiologic studies are not available to assess whether hypersensitivity vasculitis is associated with any specific ethnic group or skin type. (medscape.com)
  • Although hypersensitivity vasculitis appears to affect men and women in approximately equal numbers, some of the studies from Spain suggest that hypersensitivity vasculitis is slightly more common in men than in women. (medscape.com)
  • Hypersensitivity vasculitis may occur at any age. (medscape.com)
  • Vasculitis is primarily caused by leukocyte migration and resultant damage. (wikipedia.org)
  • We report a rare case of neonatal vasculitis presenting with skin manifestations similar to infection-based cellulitis. (scielo.org.za)
  • Condition of some disorders have vasculitis as their main feature. (wikipedia.org)
  • Skin eruptions may be a symptom of systemic disorders other than infections, and may be prominent in patients with vasculitis disorders. (scielo.org.za)
  • Any primary or secondary vasculitis can affect the skin, including that due to serum sickness, infections (eg, hepatitis C), cancers, rheumatologic or other autoimmune disorders, and hypersensitivity to drugs. (msdmanuals.com)
  • Tremendous progress over the last few decades has transformed vasculitis from frequently fatal into a chronic, manageable illness. (nih.gov)
  • Vasculitis can be mild or severe, short-term or chronic. (mountsinai.org)
  • ABSTRACT: In the case reported here, cocaine abuse led to levasimole-induced vasculitis and chronic ulcers. (bcmj.org)
  • This case and others reviewed suggest that early recognition of levasimole-induced vasculitis is needed to prevent ulcers from developing and becoming chronic. (bcmj.org)
  • Cryoglobulinaemia may cause cutaneous vasculitis and glomerulonephritis, potentially leading to end stage renal failure. (uni-muenchen.de)